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Abstract 
Angiotensin Converting Enzyme (ACE) IID, and a actinin 3 (AC1N3) R577X 
polymorphisms have been linked to the strength and power performance of elite athletes and 
suggested to influence skeletal muscle function in the general popUlation. This research 
investigated the association of these two candidate gene polymorphisms with the muscle 
function of young and older men, and the distribution of these genotypes in frequent fallers 
compared to controls. Muscle function measurements of young and older men included 
isometric strength, absolute and relative isokinetic strength at high velocity (ratio of torque 
at 2400 ·s"; torque at 30°·s") and the time course of an evoked twitch. Additionally body 
composition was measured by skinfold thickness (young men) and DXA scanning (old men) 
to estimate fat-free mass, an index of muscularity, and fat mass. ACE and AC1N3 
genotypes were determined from whole blood samples using polymerase chain reaction, and 
serum ACE activity using spectrophotometry. The gemtypes of frequent fallers referred to a 
Falls Clinic were compared to a control group of healthy men. ACE genotype was not 
associated with any measure of muscle function, including the time course of an evoked 
twitch or absolute and relative high velocity torque, or body composition in these 
populations (ANOVA, 0.12<P<0.97). Serum ACE activity appeared to be weakly associated 
with knee extensor (R = 0.19, P = 0.07) and elbow flexor (R = 0.20, P = 0.06) isometric 
strength in older men, and was negatively correlated with the relative torque at high velocity 
(R = -0.23, P = 0.03). AC1N3 genotype was associated with fat mass in older men (P = 
0.04), but was not associated with any measure of muscle function or muscularity (Kruskal-
WaIIis, 0.26<P<0.95). Finally there was no apparent difference in the distribution of ACE 
IID (r: = 0.54, P = 0.77) and AC1N3 RIX (r: = 0.76, P = 0.68) genotypes between frequent 
fallers and controls. Any influence of these individual polymorphisms seems unlikely to be 
of sufficient magnitude to produce genotype related differences in muscle function in young 
or older free living UK Caucasian men. Serum ACE activity may have a small association 
with the isometric and dynamic strength of older men. However, AC1N3 genotype was 
associated with increased fat mass in XX individuals, that suggests this polymorphism may 
have an association with the accumulation of body fat over the life span of older men. 
Key words: ACE, AC1N3 , age, contractile properties, frequent fallers, muscle strength, 
muscle function. 
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Chapter 1 
1 Introduction 
The ability to perfonn movement is a fundamental feature of life that is an essential 
component to the weII-being and survival of man. A requirement for human movement 
is the generation of force by skeletal muscles, producing torque and movement of the 
skeleton (Fitts et al., 1991). The maximum force or torque generated by a muscle or 
muscle group is defined as skeletal muscle strength (Lieber, 2002). The physiological 
factors that determine muscular strength have been extensively researched and 
encompass a range of morphological, neurological and task specific factors (Maughan et 
al., 1984; Ikai et al., 1967; Marginson and Eston, 2001) 
An individual's muscular strength reaches its peak during the third decade of life and is 
weII maintained until 50 years old (Deschenes, 2004). Beyond the fifth decade of life, 
strength tends to decrease at a pace of -15% per decade (Larsson et al., 1979). A 
reduction in physical function due to lower strength and power in old age can have a 
profound effect on a person's ability to live independently, as carrying out daily tasks 
such as rising from a chair, or climbing stairs becomes increasingly difficult. Poor 
physical function in old age leads to an increased risk of older adults developing 
disabilities (Roubenoff, 2000) therefore, understanding the basis of dysfunction of 
muscle in old age has important clinical and social implications (Frontera et al., 2000). 
A primary mechanism for the decrease in strength with ageing is sarcopema - a 
progressive loss of muscle mass. Muscle power output and the ability to produce force 
quickly appears to decline more rapidly than strength (Metter et al., 1997; Skelton et al., 
1994), which could be due to a preferential atrophy of type II muscle fibres (LexeII, 
1995). The evoked contractile (twitch) response of the quadriceps has been found to be 
-10% slower in older compared to younger persons (Roos et al., 1992) and may reflect a 
slowing of the contractile properties that contributes to the decline in power. From a 
functional perspective dynamic strength and power are considered to be more relevant 
than isometric strength (Wilson & Murphy, 1996). 
2 
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This loss of strength and power of the lower limb muscles is a primary risk factor for 
falling (American Geriatrics Society, 2001). Falls are a major health issue for the ageing 
population as they increase morbidity, contribute to decreased quality oflife (Robbins et 
al., 1989) and create a high financial burden. Falls also lead to an increased fear of 
falling, reduced activity and can cause a downward spiral of inactivity-related disability 
(Simey et al., 1999). 
Genetic factors appear to account for a substantial proportion of the phenotypic 
variability of muscle strength and function. In young men, the genetic contribution to 
strength and power appears to be 30-80%, depending on the nature of the functional test 
employed (Thomis et al., 1998; Calvo et al., 2002). The heritability of strength, power 
and walking speed has been found to be 34-52% in older men (Carmelli et al., 2000; 
Tiainen et al., 2007). Finding the specific genetic variants responsible for this 
heritability in muscle function will enhance our understanding of the mechanisms 
regulating muscle strength. 
The annual publication of the human gene map for performance and health related 
fitness phenotypes (Rankinen et al., 2006) list more than 200 genes or genetic regions 
associated with athletic performance and physical fitness traits. The angiotensin 
converting enzyme (ACE) IID and a actinin 3 (ACTN3) R577X polymorphisms have 
recently been identified as potential influences contributing to variations in skeletal 
muscle composition, function and performance (Williams et al., 2005; Mills et al., 
2001). 
A functional polymorphism of the ACE gene is defined as the presence (insertion, I 
allele) or absence (deletion, D allele) of a 287 amino acid base pair Alu repeat sequence 
within intron 16 of the ACE gene on chromosome 17 (Rigat et al., 1990). This 
polymorphism results in the genotypes 11, ID and DD with representation among 
Caucasian Europeans of -24, 50 and 26% respectively (Myerson et al., 1999). Case 
control stndies have reported a higher frequency of the DD genotype in sprint athletes 
compared to endurance athletes and controls (Myerson et al., 1999; Woods et al., 2001; 
3 
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Nazarov et al., 2001), indicating that this genotype may influence skeletal muscle 
function. The D allele variant of the ACE gene is associated with higher concentrations 
of serum ACE activity (Rigat et al., 1990). ACE catalyses the production of Angiotensin 
II (ANG II), which appears to enhance skeletal muscle hypertrophy (Gordon et al., 
2001; Westercamp and Gordon, 2005) and degrades kinins (Brown et al., 1998), which 
have growth inhibitory properties (Ishigai et al., 1997). There is recent evidence that 
ACE genotype influences two important determinants of muscle strength and power; 
muscle size (Charbonneau et al., 2008) and fibre type composition (Zhang et al., 2003). 
The D allele has been associated with greater isometric strength in COPD patients 
(Hopkinson et al., 2004) and the isometric and isokinetic strength of healthy young men 
(Williams et aI., 2005). However several investigations have found no association of 
ACE genotype with isometric and dynamic strength in young and older adults (Folland 
et al., 2000; Fredericksen et aI., 2003; Thomis et al., 2004; Pescatello et al., 2006; 
Woods et al., 2001b). 
A common genetic variation in the ACTN3 gene results in the replacement of an 
arginine (R), the normal functional allele, with a stop codon (X) at amino acid 577 
(R577X) that negates the production of the functional ACTN3 protein (North et al., 
1999). This polymorphism results in the genotypes RR, RX and XX with representation 
among healthy Caucasian Australian adults of30, 52 and 18% respectively (Yang et al., 
2003). 
ACTN3 expression is restricted to the fast glycolytic (type IIX) muscle fibres (Mills et 
al., 2001) and the absence of ACTN3 could inhibit the performance of these fibres that 
are important for rapid powerful contractions (MacArthur and North, 2004). The 
mechanistic actions of ACTN3 deficiency are currently being explored. Muscle from 
ACTN3 knockout (KO) mice was found to have a slower contractile response and lower 
force generating capacity than those with ACTN3 (Chan et al., 2008). Furthermore KO 
mice show a reduced fast twitch fibre diameter, lean mass and total body mass compared 
with wild type mice (MacArthur et al., 2008) suggesting a clear effect of ACTN3 
genotype on skeletal muscle growth and muscularity. Case control studies have reported 
4 
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a higher frequency of the RR genotype in sprint, strength and power athletes compared 
with endurance athletes and controls (Niemi et al., 2005; Yang et al., 2003 Roth et al., 
2008; Druzhevskaya et al., 2008; Papadimitriou et al., 2008), indicating a beneficial 
effect on skeletal muscle function. Moreover ACTN3 genotype has been found to 
influence fibre type composition (Vincent et al., 2007). However the evidence from 
cross sectional association studies remains equivocal with some reports of ACTN3 
genotype influencing muscle strength of females but not males (Clarkson et al., 2005; 
Delmonico et al., 2007), but others have found no influence on muscle strength in either 
sex (Delmonico et aI., 2008; Moran et a!., 2007). 
Many of the previous reports studying the associations of ACE IID and ACTN3 R/X 
polymorphisms with muscle strength and function have studied populations with a 
mixed ethnic origin (Pescatello et al., 2006), a wide age range (Clarkson et al., 2005; 
Walsh et al., 2008) or variable physical activity status (Woods et al., 2001; Hopkinson et 
al., 2004), which could confound results. For example skeletal muscle phenotypes are 
known to be influenced by ethnic origin (Newman et al., 2003). The majority of these 
studies have assessed isometric strength as the only muscle function measure 
(Frederikson et al., 2003; Hopkinson et al., 2004; Moran et al., 2006; Moran et al., 
2007), which may not be as functionally relevant as dynamic strength. To date no 
studies have examined the associations of ACE and ACTN3 genotype with high velocity 
muscle strength and the contractile properties of younger and older males. The vast 
majority of the previous studies have examined the association of only single gene 
polymorphisms with muscle function. Considering that the influence of a single gene 
variant is probably quite small (Williams and Folland, 2008) any association of 
candidate genes should be investigated together in order to determine broader genetic 
effects on a given phenotype. Therefore studies of multiple candidate genes are required. 
The aim of this research was to investigate the association of two candidate gene (ACE 
IID and ACTN 3 R/X) polymorphisms with the muscle function of young and older 
men, and the distribution of these genotypes in frequent fallers compared to controls. 
The first experiment (Chapter 3) examined knee extensor muscle function of healthy 
5 
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young Caucasian men. A novel aspect of this study and Chapter 5 was the measurement 
of high velocity strength and contractile properties. Considering the importance of 
muscle strength and power to healthy ageing the second and third studies examined the 
association of ACE IID and ACTN3 RIX polymorphisrns with muscle function and body 
composition phenotypes of older Caucasian men. The fIrst of these studies (Chapter 4) 
was in part a preliminary trial, but the second (Chapter 5) was a comprehensive 
investigation that included strength measures from a range of upper and lower body 
muscle groups and assessment of non-skeletal lean mass by dual energy x-ray 
absorptiometry (DXA). The fourth and fInal study (Chapter 6) investigated the 
frequency of ACE and ACTN3 genotypes in frequent fallers compared to a control 
population. 
6 
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Chapter 2 
2.1 Muscle Structure and Contraction 
The ability to perform movement is a fundamental feature of life that is essential to the 
well being and survival of man. A requirement for human movement is the generation of 
force by skeletal muscles, producing a torque and movement of the skeleton (Fitts et al., 
1991). 
2.1.1 The structure of skeletal muscle 
Skeletal muscle comprises approximately 40% of total body weight. A skeletal muscle is 
a collection of muscle fibres (cells) that are bound with connective tissue and arranged 
with their long axis in parallel (Figure 2.1). The connective tissue surrounding the fibres 
is contiguous with the tendon that attaches the muscle to adj acent or in series bones. 
Groups of muscle fibres that function together and the motor neuron that innervate them 
are called a motor unit. Larger muscles such as the quadriceps femoris of adult humans 
contain several hundred thousand fibres organised as many motor units. Each skeletal 
muscle fibre is long and cylindrical in shape, and multinucleated with several hundred 
nuclei at the periphery of the fibre (Figure 2.1). Collagen, elastic fibres, nerves, 
capillaries and blood vessels are found between the bundles of muscle fibres (Martini, 
2001). 
The sarcolema or cell membrane surrounds the cytoplasm of the muscle fibre that 
contains -2,000 myofibrils in human adult fibres (Martini, 2001). Each myofibril is 
surrounded by a webbing structure known as the sarcoplasmic reticulum, which releases 
Ca2+ when depolarisation spreads along the sarcolemma and into the fibre via the T-
tubules. Myofibrils consist of a longitudinally repeating structure, known as the 
sarcomere, that contains the contractile filaments (proteins) actin and myosin. These 
filaments are responsible for force generation (Martini, 2001) and are arranged in a very 
precise hexagonal array within a scaffold of structural proteins (e.g. titin). 
8 
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Figure 2.1 Basic structure of skeletal muscle (themedicalbiochemistrypage.org). 
2.1.2 The sliding filament theory 
Chapter 2 
The sliding filament theory proposes that muscle fibres shorten or lengthen because 
thick and thin filaments slide past each other without the filaments themselves changing 
length. When Ca2+ is present within a myofibril the myosin cross bridges cyclically 
attach, rotate, and detach from the actin thin filaments (with energy provided by A TP 
hydrolysis), driving the shortening process. Essentially during concentric activity the 
actin filaments are pulled passed the myosin filaments shortening the I band and 
reducing the length of the sarcomere. As all the sarcomeres in a muscle fibre and indeed 
within a motor unit are also shortening simultaneously this applies tension to the tendon 
and ultimately the skeleton generating torque about the joints. An isometric muscle 
contraction generates force while the fibres length remain relatively unchanged. In this 
situation the relative spacing of I and A bands remains constant as there is minimal 
movement of the actin filaments passed myosin. In contrast the A band widens when a 
muscle generates force while lengthening in an eccentric contraction (McArdle et al., 
2000). 
9 
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2.2 Factors affecting skeletal muscle strength 
The strength of skeletal muscle is defined as its capacity to produce active tension and 
thus force or torque (Hislop and Perrine, 1967). It is thought to depend on a number of 
morphological, neurological and task specific factors. The main factor influencing 
strength is the cross sectional area of the muscle (Maganaris et al., 2001; Holmback et 
al., 2002). Additional factors include, muscle architecture (Lieber, 2002), the muscle's 
length tension relationship (Marginson and Eston, 2001), fibre type composition 
(Aagaard and Andersen, 1998), the velocity at which the movement takes place (Gaines 
and Talbot, 1999) and the extent to which the muscle can be activated by voluntary 
effort (Gandevia and McKenzie, 1988). 
2.2.1 Measurements of skeletal muscle strength 
Muscular strength can be assessed with isometric, isokinetic and isoinertial 
measurements. Isometric assessment involves a muscle contraction with no noticeable 
muscle lengthening or shortening i.e. the body segment remains stationary and 
displacement is zero. Isometric tests are considered highly reliable, easily administered, 
require little skill involvement and are relatively inexpensive (Mital and Kumar, 1998). 
However isometric measurements are not considered to be a good representation of the 
capacity for functional movements, which are dynamic and occur throughout a range of 
movement rather than at just one joint angle (Wilson & Murphy, 1996). 
Isokinetic assessment involves movement at a constant velocity, with the resistive torque 
accommodating to the individual's net joint torque which changes throughout the range 
of motion (Adams, 1998). Accommodating resistance enables the active musculature to 
contract at its maximum ability at all points through its range of motion (Arrnundsen, 
1990). Isokinetic measurements possess high internal validity (Abernethy et al., 1995). 
10 
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Isoinertial measurement involves the generation of force or torque against a resistance of 
constant inertia or mass. In practice a participant's maximal lifting capacity with free 
weights provides an assessment of their isoinertial strength for a given exercise e.g. 
bench press. As free weights are widely available this is a practical and relatively quick 
assessment of strength. 
2.2.2 Morphological Factors influencing Strength 
2.2.2.1 Muscle size, Cross sectional area (CSA) and Muscularity 
The maximum voluntary isometric force which can be produced by human skeletal 
muscle is partly detennined by the muscle cross sectional area (Lieber, 2002). 
Theoretically the force generated by the contractile elements depends on the number of 
actin and myosin filaments arranged in parallel, rather than in series (Jones, 1992). The 
geometric measurement that captures the number of cross-bridges in parallel is CSA. 
Therefore a larger muscle with a greater CSA has a greater number of cross bridges in 
parallel and would be expected to produce more force. 
Anatomical cross sectional area (ACSA) is a convenient measurement of muscle size 
that is made perpendicular to the long axis of the muscle, which can be obtained by a 
variety of scanning techniques including magnetic resonance imaging (MRI). Several 
studies have demonstrated a moderate to high correlation between ACSA of a muscle 
and maximum voluntary force (Maughan et al., 1984; Narici et al. 1989). Maughan et al. 
(1984) examined muscle strength and cross sectional area and reported that the cross 
sectional area of a muscle accounts for approximately 50% of the difference in 
maximum voluntary knee extension force between individuals. 
However in pennate muscles, (as is the case for most locomotor muscles) the muscle 
fibres run at an angle to the axis of traction of the muscle. This geometrical arrangement 
of fibres can directly influence the amount of force generated through voluntary 
contraction, and the ACSA does not represent the cross section perpendicular to the 
fibres in the muscle. (Lieber, 2002). In this case the physiological cross sectional area 
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(PCSA) measured perpendicular to the direction of the muscle fibres, is thought to better 
represent the contractile ability of the fibres and their collective cross sectional areas 
(Maughan et al., 1984). 
Furthermore Bamman et al. (2000) examined plantar flexor isometric strength in a 
cohort of 39 women. CSA was measured with magnetic resonance imaging (MR!). 
Isometric strength showed significant correlations with ACSA and PCSA (54 and 51 % 
of strength explained by ACSA and PCSA, respectively). Additionally using MRI, 
Akima et al. (2001) tested isometric knee extensor strength in a group of men. Results 
demonstrated a significant correlation between PCSA of the quadriceps femoris and 
peak force in men demonstrating 34% of strength explained by CSA. These studies have 
shown that muscle size, assessed by ACSA or PCSA, appears to be the most important 
single determinant of strength. 
Whole body muscularity is normally inferred from body composition measurement of 
fat-free mass (FFM). Methods of determining FFM include skinfold thickness, 
bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA). 
The principle behind the technique of skinfold thickness is that the amount of 
subcutaneous fat is proportional to the total amount of body fat. It is assumed that close 
to one third of the total fat is located subcutaneously. Regression equations are used to 
convert the sum of skinfolds to percent body fat. Body composition determined from 
skinfolds correlates well (0.70-0.90) with body composition determined by 
hydrodensitometry (the standard method for measuring body composition). The 
accuracy of predicting percent fat from skinfolds is approximately ± 3.5% assuming that 
appropriate techniques and equations have been used (ACSM, 2010). BIA determines 
the electrical impedance, or opposition to the flow of an electric current through body 
tissues which can then be used to calculate an estimate of total body water (TBW). TBW 
can be used to estimate fat-free body mass and, by difference with body mass, body fat 
(Eston and Reilly, 1996). The accuracy of BIA is similar to skinfolds as long as stringent 
protocol is followed and the equations programmed into the analyser are valid and 
accurate for the population tested (ACSM, 2010). DXA can be used to assess total bone 
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mass as well as regional estimates of bone, fat and lean tissue. It uses a 3 components 
model to predict body fatness and is a reliable and accurate measure of body 
composition (ACSM, 2010). 
2.2.2.2 Muscle architecture 
The force developed by pennate muscle fibres acts at an angle to the long axis of a 
muscle. The component of force, which acts along the length of a muscle, is equal to the 
cosine of the angle of pennation. The PCSA represents the maximal number of acto-
myosin cross bridges that can be activated in parallel during contraction (Fukunaga, 
2001). Based on the parallelogram models ofbipennate muscle, total physiological cross 
sectional area increases in proportion to sin (Op), where Op is the muscle fibre 
pennation angle. Greater pennation angles would result in more contractile material 
attached to a larger area of the tendon and therefore greater total force produced by the 
fibres (Kawakami et al., 1993). However, the contractile force transmitted from the 
fibres to the tendon decreases as the angle of pennation increases according to cos (Op). 
From mathematical modelling of these opposing effects, maximum muscle force is 
expected to increase with fibre pennation angle up to an optimum of 45° (Rutherford and 
Jones, 1992). As a consequence, all other factors being equal, pennate muscles are 
stronger than non-pennate muscles (Lieber, 2002). 
2.2.2.3 Specific tension 
The intrinsic force generating capacity of the muscle fibres is known as specific tension 
and it is expressed as the force that a muscle fibre can exert per unit of CSA (N·cm·2) 
(Fitts et al., 1991). It has been suggested that specific tension differs according to muscle 
fibre types and that this could influence muscle function and strength. If this were the 
case then a muscle rich in type II fibres would produce more force than a muscle high in 
type I fibres (Burke, 1967). 
Fitts et al. (1991) reported a 24% difference in specific tension between type I and II 
fibres (1.36 and 1.69 kg·cm·2, respectively). In vivo specific tension of the soleus and 
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tibialis anterior muscles in man were calculated to be 150 and 155 kN'm-2, respectively 
(Maganaris et al., 2001). Further more Larsson and Moss (1993) reported on human 
skinned and freeze dried muscle fibres in which specific tension of type I and type 11 
fibres was -120 and 180 kN/m2, respectively, indicating that specific tension may be 
fibre type dependent. 
Recent findings suggest greater specific tension of hwnan fibres expressing myosin 
heavy chains (MHC) IIX isoform than fibres expressing only MHC I (+50%, Stienen et 
al., 1996; +20%, Bottinelli et al., 1999; +32%, Widrick et al., 2002). Consequently fibre 
type composition does appear to influence specific tension and likely exerts a small 
influence on the isometric strength of hwnan skeletal muscle. The influence of fibre type 
composition on muscle function during dynamic contractions is addressed. 
2.2.3 Task Specific Factors 
2.2.3.1 Angle-torque relationship 
The change in joint torque as a result of changes in muscle length is well docwnented 
both in-vivo and in-vitro. As the angle of a joint alters, the length of the muscle(s) acting 
over that joint also changes. This leads to the arrangement of the contractile filaments in 
the sarcomere to change, in particular the overlap of actin and myosin filaments, which 
affects force generation (Jones, 1992). Gordon et al. (1966) first described the length-
tension properties of skeletal muscle sarcomeres. They reported that peak active tension 
was constant across a sarcomere length of 2.0-2.2 !lm. At this length, optimal overlap 
exists between the myosin and actin filaments, which is turn produces the maximal 
nwnber of cross-bridges and therefore peak force. At progressively longer sarcomere 
lengths, active tension decreases linearly, reaching zero at 3.6 !lm. Below sarcomere 
lengths of 2.0 !lm force during an isometric contraction falls due to overlap of the thin 
filaments from opposite ends of the sarcomere and to an increase in the filament lattice 
spacing (AlIen and Moss, 1987). This relationship can be plotted on a graph and 
demonstrates a length-tension curve. 
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It has been demonstrated that the length-tension relationship in-vivo does not entirely 
reflect the same characteristics as an isolated muscle due to in-situ biomechanical factors 
such as the tendon and joint mechanics (Kawakami and Lieber, 2000). In-vivo the 
relationship is referred to as the angle-torque relationship (Figure 2.2). Marginson and 
Eston (2001) investigated the relationship between torque and joint angle during knee 
. extension in males. These authors documented a characteristic torque-joint angle curve 
in which torque increased until an optimal joint angle of 80·, after which it began to 
decrease. 
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Figure 2.2 In-vivo angle-torque relationship at 3 velocities (Reproduced from Folland and Morris, 2008). 
2.2.3.2 Torque-angular velocity relationship 
This is the relationship between the maximum torque and the corresponding velocity of 
muscle lengthening and shortening. The maximal torque a muscle can produce decreases 
with an increase in the velocity of shortening (Herzog, 2000). Since the early work of 
A.V. Hill (1938), this relationship for isolated skeletal muscle has been known to be 
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hyperbolic. As the velocity at which the actin and myosin slide past one another 
increases, a resulting lower number of attachments occur and so force decreases (Lieber, 
2002). In humans the torque-angular velocity relationship is markedly less hyperbolic, 
but does show a clear reduction in torque with an increase in the velocity of shortening 
(Figure 2.3). 
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Figure 2.3 In-vivo Torque-angular velocity relationship (Reproduced from Racz et ai., 2002). 
2.2.4 Fibre type composition and the/unction o/skeletal muscle 
Human skeletal muscle fibres can be divided into the following groups I, I-IIA, IIA-IIX 
and IIX by using myosin heavy chain isoforms (Bottinelli et al., 1999). Fast twitch fibres 
(type 11) show considerably higher maximal shortening speeds and power outputs than 
slow twitch fibres (type I). In rat skeletal muscle fibres the maximal shortening velocity 
is 5-6 fold higher in the type IIX than type I, while the type IIA is 3-4 fold higher than 
the type I (Fitts et al., \989). Bottinelli et al. (1999) measured the maximum velocity 
shortening and power output of different types of human skeletal muscle fibres. 
Maximum power output was - 9 times higher in type IIX fibres compared to type I; the 
velocity at which maximum power was achieved showed large and significant variations 
(about 4 times) between fibre types (Figure 2.4). Additionally the difference in velocity 
of shortening was approx. 4 times between the fastest and the slowest group of fibres. In 
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human skeletal muscle Faulkner et al. (1986) showed the peak power output of the type 
II fibres was fourfold that of the type I fibres. Additionally it was shown that the muscle 
with 50% type II and 50% type I fibres had a peak power that was 55% of the peak 
power for a muscle composed exclusively of type II fibres. Consequently muscles 
composed of type I fibres are at a disadvantage in performing tasks requiring substantial 
power development (Faulkner et al., 1986). 
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Figure 2.4 Power-velocity curves for each fibre type (Reproduced from Bottinelli et al., 1999). 
Force production depends on the binding of the myosin head to actin. The force-velocity 
relationship is likely to reflect the kinetic properties of the cross bridges and attempts 
have been made to evaluate the various steps in the cross bridge cycle using the 
infonnation provided by the force-velocity curve. There is reason to believe that the 
maximum speed of shortening expresses the maximum cycling rate of the cross bridges. 
In support of this the maximum speed of shortening had been found to correlate with the 
splitting of ATP within the contractile system. This was first demonstrated in studies of 
the whole muscle (Barany, 1967) and later in a more quantitative way (Edrnan et al., 
1988) by comparing the maximum speed of shortening and myofibrillar ATPase activity 
in isolated single muscle fibres and showed an increase in ATPase activity as velocity of 
unloaded shortening increased. Furthennore the speed of relaxation of the muscle is 
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related to the activity of the myosin ATPase and the re-uptake of calcium by the 
sarcoplasmic reticulum, these properties being different in the different fibre types 
(Rutherford et al. 1995). 
Aagaard and Andersen (1998) investigated the correlation between contraction strength 
and myosin heavy chain composition in human skeletal muscle. The percentage of 
myosin heavy chain II (MHC) in the quadriceps muscle was positively correlated to 
maximum concentric quadriceps strength obtained at medium to high knee angular 
velocity (120··s·1 and 240··s-I). It was suggested that the relationship between muscular 
MHC composition and maximal contractile strength appears as a consequence of the 
MHC-related difference in contractile force-velocity characteristics. A growing body of 
evidence suggests that the ratio of muscle torque produced at fast versus slow speeds is 
highly correlated to the area and isoform profile of muscle fibres (Gur et al. 2003; Ivy et 
al. 1981; Suter et al. 1993). In particular Gur et al. (2003) found the ratio of maximum 
isokinetic torque at 2400 ·s-1 to that generated at 300 ·s-l , correlated (r = 0.74; P < 0.001) 
with the relative area of type II fibres. On the basis of this evidence, isokinetic 
dynamometry may have the sensitivity to detect substantial individual differences in 
fibre type composition or even subtle differences between groups. 
Furthermore the concept of examining the speed of relaxation of a muscle from a 
contraction in order to infer fibre type has already been applied to studies of tendon 
reflexes and brief electrically stimulated contractions (Lambert et al. 1951). Time to 
peak tension (TPT) and half relaxation time (HRT) have been previously used to infer 
fibre type composition (Hamada et al. 2000), suggesting that short TPT and HRT 
reflects a high percentage of type II fibres. This suggestion concurs with an early study 
by Burke et al. (1973) in which the physiological properties of single motor units were 
studied in the gastrocnemius muscle (primarily in the medial head) of cats. Results 
showed that the units studied could be classified into one of three major fibre types, 2 of 
which exhibited relatively short twitch contraction times (types IIA and IIX), and one 
group with relatively long contraction times (type I). 
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In order to function a muscle must have an intact nerve supply and force generation is 
determined by the number of motor units recruited as well as their firing frequency 
(lones, 1992). When the greatest number of motor units is recruited in combination with 
the highest firing frequency, then maximal force is obtained. Early evidence from . 
Merton (1954) demonstrated the ability to maximally activate a muscle during a 
voluntary effort. It has also been put forward that during maximal efforts most major 
muscle groups can be fully activated without training (Jones, 1992; Kent-Braun and 
LeBlanc, 1996). 
However the majority of recent evidence suggests that skeletal muscle cannot be fully 
activated by voluntary effort, (Ikai, 1967; Hakkinen et a!., 1986; Herbert and Gandevia, 
1999) and there are many muscles that the average person is unable to control; trivial 
examples include the muscles involved in moving ears and eyebrows but it is possible 
that major muscle groups may not be fully used. In support of this idea, Ikai (1967) 
documented that during maximum contractions force produced by the thumb adductor 
muscle in response to tetanic stimulation was 30% greater than that which could be 
produced by voluntary effort. More recent studies concur with this suggestion (Hakkinen 
et al., 1986; Herbert and Gandevia, 1999). Additionally evidence indicates that 
voluntary activation declines as a consequence of inactivity (Kawakami et al., 2001), in 
which 20 days bed rest resulted in a 6% reduction in the extent to which knee extensors 
could be activated. This suggests that inactive individuals are less likely than active 
individuals to be able to maximally activate skeletal muscle. 
The maximality of neurological activation may be muscle and joint position / muscle 
length specific. For example the elbow flexors appear to be more completely activated 
than the quadriceps femoris during maximum isometric efforts (Belanger and McComas, 
1981). Kubo et al. (2004) also reported that the activation level of quadriceps femoris 
was highest at the knee flexed positions (80-11 0°) than at extended positions (40-70°) 
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suggesting that the activation level of an agonist muscle is higher at longer than shorter 
lengths. 
The inability to fully activate muscle during an MVC may be a consequence of a lack of 
neural drive from supraspinal centres or inhibitory input from sensory afferents 
including muscle mechanoreceptors, golgi tendon organs or joint receptors. This 
protective mechanism may inhibit individuals from completely activating all their motor 
" 
units within a specific muscle group (Kendall et al., 2006) consequently reducing the 
capacity to create maximal force. 
2.2.5.2 Antagonist activation 
It is known that muscle activation is not confmed to the agonist, but is generally seen in 
the antagonist as well, appearing as a burst of antagonist activity if the movement is 
quite rapid (Karst and Hasan, 1987). Kubo et al. (2004) reported that the co-activation of 
an antagonist to knee extension, the biceps femoris at 90-110· was significantly higher 
than at the other knee angles, suggesting that co-activation of an antagonist muscle is 
higher at longer lengths. Furthermore Baratta et al. (1988) showed co-activation of the 
knee flexors during knee extension tasks at various joint angles. Co-contraction of 
antagonists reduces torque output, but may also impair, by reciprocal inhibition, the 
ability to fully activate the agonists (Folland and Williarns, 2007). Greater co-activation 
can reduce the performance of agonist muscle and therefore the torque produced 
(Carolan and Cafarelli 1992). 
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2.3 Strength and Power in Old Age 
2.3.1 Loss of strength as a consequence of ageing 
Frontera et al. (1991) assessed the isokinetic strength of the elbow and knee extensors 
and flexors in 200 healthy 45 to 78 year old men and women to examine the relationship 
between muscle strength, age, and body composition. Peak torque was measured at 60 
and 240··s·! in the knee and at 60 and 180··s·! in the elbow with an isokinetic 
dynamometer. Strength of all muscle groups at both velocities was significantly lower 
(range 16-27%) in the 65-78 than the 45-54 yr old men and women. When strength was 
adjusted for fat free mass (FFM) and muscle mass (MM) the age-related differences 
were not significant in all muscfe groups except the knee extensors tested at 240··s·! 
suggesting that reduced muscle mass accounts for a high proportion of the decline in 
strength with age. Based mostly on cross sectional studies the mean annual loss of 
strength among healthy people from 30-70 years of age has been estimated to be 0.5-1 % 
when comparing the isokinetic torque of young and older persons (Akima et al., 2001; 
Zu et al., 2007). The loss of strength over time is larger in longitudinal studies (Bassey 
et al., 1993; Fronte~a et al., 2000) than in cross sectional studies indicating that cross 
sectional studies may underestimate the age related changes in muscle function. 
Bassey et al. (1993) investigated grip strength over a four year period in a large cohort 
of over 65 year old men and women and found a 2% per year decline. In a more recent 
longitudinal study the overall rate of loss of strength in the quadriceps and hamstrings 
has been reported to be 2 and 2.4% per year and hand grip strength decreased by -3% 
per year (Frontera et al., 2000) in a cohort initially aged 65.4 ± 4.2 yrs. Additionally 
isokinetic muscle strength of the knee extensors and flexors and elbow flexors showed 
losses ranging from 1.7-2.5% per year at slow and fast angular velocities (Frontera et al., 
2000). Furthermore Frederiksen et al. (2006) carried out a longitudinal study of Danes 
aged 45 to 102 years and reported an annual decline in grip strength with increasing age 
of 1.4% in men and 1 % in women over 4 years. 
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2.3.2 Loss of muse le Power 
Skelton et al. (1994) measured isometric knee extensor, isometric elbow flexor and 
handgrip strength and leg extensor power in 50 men and 50 women (65-89 yrs). In men 
and women the rates of loss of leg extension power were 3.7% and 3.2% per year 
respectively. The rate of decline over this age range was 1-2% year for isometric 
strength and 3.5% per year for leg extensor power. Additionally over a 25-year period 
Metter et al. (1997) measured strength and power every 2 years and found the decline to 
begin by age 40 in both women and men. After which power declined about 10% more 
than strength in men. Confirming that muscle power output and the ability to produce 
force quickly appears to decline more rapidly than strength. This affects the torque 
power-velocity relationship and data from young and elderly men shows the estimated 
maximum shortening velocity (Vmax) of the plantar flexor muscles of the elderly is 16% 
lower that that of the young (Narici and Maganaris, 2006). The graph below 
demonstrates the reduction in power and torque at various velocities between young and 
old men as a consequence of ageing (Figure 2.5). 
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Figure 2.5 The torque and power-velocity relationships for young (YM) and older (OM) men. At all 
velocities, the younger men were significantly stronger than the older men (P < 0.001). (Reproduced from 
Thorn et al., 2007). 
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2.3.3 Sarcopenia 
A primary mechanism for this reported decrease in strength and power is sarcopenia - a 
progressive loss of muscle mass (Frontera et al., 1991). In a cross sectional study 
Janssen et al. (2000) examined the influence of age on skeletal muscle mass with whole 
body magnetic resonance imaging of 468 men and women. They observed a reduction in 
skeletal muscle mass starting in the third decade primarily attributed to a decrease in 
lower body skeletal muscle. Skeletal muscle mass declined by 17.1 % in females and 
26.3% in males between the youngest age group (18-20 yrs) and the oldest group (+70 
yrs). 
In a 12 year longitudinal study Frontera et al. (2000) examined the age related changes 
in skeletal muscle size and function in older men and women (initial age 65 years). A 
significant reduction in muscle CSA in leg muscles over the 12-year period was 
reported, ranging form 12.5% to 16.1%. It was estimated from this study that the 
reduction in muscle CSA after 50 years of age was 1.4% per year and suggested that this 
is a major contributor to the decrease in muscle strength seen with advancing age. 
2.3.4 Fibre type, number and size 
Sarcopenia and the decline in the size of whole muscles with age could theoretically be 
caused by a reduction in the number of muscle fibres, a reduction in the size of muscle 
fibres (atrophy) or a combination of the two. In humans muscle fibre size reaches its 
peak in the third or fourth decade of life and thereafter gradually decreases (Larsson, 
1978). Early investigations reported fibre type distribution changed towards a decrease 
in the percentage of type II fibres due to ageing (Larsson et al., 1978; Jakobson et al., 
1988). In a study by Larsson et al. (1978) biopsies were taken from the vastus lateralis 
. muscle of 55 untrained, healthy male subjects from 22 to 65 years of age. Fibre type 
distribution changed towards a decrease in the percentage of type II fibres, both in type 
IIA and type IIX fibres, whereas type IIXllIA fibre ratio did not change with increasing 
age. It was found that the type IIXllIA fibre ratio was inversely related to type I fibres, 
i.e. subjects rich in type I fibres had a relatively smaller proportion of type IIX fibres. 
Fibre area determinations revealed a selective decrease in type 11 fibre area. 
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Consequently, the type IIII fibre area ratio and relative type II fibre area decreased. 
Lexell et al. (1988) carried out a human autopsy on whole vastus lateralis (VL) muscle 
from 43 men between 15 and 83 years old. Results indicated that ageing begins at 25 
years and progressively accelerates, mainly caused by a quantitative loss of fibre 
number. In the most thorough study of this topic to date Lexell and Taylor (1991) 
investigated cross sections of whole VL from 20 men, 19-84 year olds. Type I and type 
II fibres were measured in 5 different regions throughout each muscle. Older individuals 
had 6% and 35% smaller mean CSA of type I and II fibres, respectively, than young 
subjects. 
Lexell et al. (1986) described in detail the age-induced alteration in muscle size and 
showed type II fibre size decreased by 20%. Additionally Andersen (2003) found 80-
year-old men had much greater atrophy of the type II fibres than type I fibres of young 
men (25 yrs). Therefore greater atrophy of type II fibres occurs with ageing, and this 
may contribute to a greater decline in muscle power than strength (Lexell, 1995). And 
considering fast twitch fibres show considerably higher maximal shortening speeds and 
power outputs then this reduction in fast twitch fibre size would have negative 
consequence for tasks involving power. 
Muscle fibre atrophy in the elderly may be associated with a specific reduction in the 
number of satellite cells in type II fibres (Verdijk et al., 2007). Satellite cells or "muscle 
stem cells" are the sole source for the generation of new myonuclei in vivo (Alien et al., 
1999) and are essential for the maintenance of skeletal muscle mass (Shefer et al., 2006). 
Fibre type specific satellite cell content from the vastus lateralis in eight elderly (76 yrs) 
and eight young (20 yrs) healthy males was assessed via muscle biopsies (Verdijk et al., 
2007). The number of satellite cells per type II fibre was substantially lower in the 
elderly compared to the young (0.044 ± 0.003 vs. 0.080 ± 0.007). Additionally in the 
type II fibres, the number of satellite cells relative to the total number of nuclei and the 
number of satellite cells per fibre area were also significantly lower in the elderly group. 
This study was the first to show type II fibre atrophy in the elderly to be associated with 
a fibre type-specific decline in satellite cell content. This decline in content might be an 
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important factor in the etiology of type 11 muscle fibre atrophy, which accompanies the 
loss of skeletal muscle with aging. 
2.3.5 Evoked twitch response with ageing 
The slowing of the contractile properties (through electrical stimulation) has been 
demonstrated in investigations of the lower limbs (Roos et al., 1999) and in the adductor 
pollicis muscle (Narici et al., 1991). The evoked contractile (twitch) response of the 
quadriceps has been found -10% slower in older compared to younger persons (Roos et 
al., 1999). The effect of ageing on the electrically evoked contractile properties of the 
human adductor pollicis muscle was investigated in 70 healthy male subjects aged 20-91 
yr, (10 subjects for each decade) (Narici et al., 1991). Maximum relaxation rate from 
tetanic stimulation dropped by 49% from the second to the eighth decade. Leg muscles 
are 10% slower in individuals over 73 yrs compared to young people in their twenties 
(Vandervoort and McComas 1986; Roos et al., 1999) as demonstrated by the longer time 
taken to reach peak tension and to relax after the twitch. The reason for this slower 
relaxation rate (or longer twitch contraction duration) is probably related to selective 
atrophy of type II fibres (Macaluso and De Vito, 2004). The muscles relax at a lower 
rate as a result of the predominance of type I fibres, which are slower. 
2.3.6 Fibre angle of pen nation 
The effect of ageing on human gastrocnemius medialis (GM) pennation angle was 
evaluated in older individuals (aged 70-81 yrs) and was significantly smaller by 10 and 
13% (Narici et al., 2003; Morse et al., 2004) than those in younger adults. Findings were 
based on ultrasound scanning, a method that has been validated by comparisons with 
direct anatomical measurements on cadaveric muscles (Narici et al., 1991; Kawakami et 
al., 1993). Modifications in muscle architecture are unlikely to be associated with 
disuse, given that in one study Narici et al. (2003) purposely matched the level of 
physical activity of young and elderly individuals. Therefore the differences betw~en 
age groups appear to have been due to the process of aging per se. 
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2.3.7 Specific tension 
Larsson and colleagues (1997) determined specific tension in 400 single quadriceps 
muscle cells of young and old men and observed age related differences in specific 
tension in type I and HA fibres. The specific tension of chemically skinned type HA 
fibres in a young group was 0.25 N/mm2 compared to 0.18 N/mm2 in the older group. In 
it more recent study biopsy samples were taken from the vastus lateralis muscle of young 
(30.2 +1- 2.2 yrs), and elderly (72.7 +1- 2.3 yrs) persons in order to evaluate the specific 
tension of single skinned muscle fibres (D' Antona et aI., 2003). The specific tension of 
type I and HA fibres was significantly lower in the older group than in the young group 
with a larger decrease in type I (-22 %) than in type HA (-16 %). Furthermore at the 
single muscle fibre level Yu et al. (2007) reported a 20-28% decline in specific tension 
of the vastus lateralis muscle fibres expressing type I MHC isoforrn in young compared 
to older men and women. 
Contrastingly Kent-Braun and Ng (1999) reported that dorsiflexor specific tension was 
unaffected by ageing and suggested that the decline in specific tension reported in other 
studies may actually be due to a reduction in physical activity and not ageing per se. 
However, the investigation by Larsson et al. (1997) and D' Antona et al. (2003) do not 
support this suggestion as both studies utilised immobilised elderly as well as physically 
active elderly participants and still reported a decline in specific tension for both groups 
compared to young adults. In contrast to Kent-Braun and Ng (1999), Macaluso et al. 
(2002) reported lower specific tension at the whole muscle level in seventy year old 
women compared to women in their twenties. The change in specific tension provides 
evidence of quantitative changes in contractile properties of human skeletal muscle with 
ageing, which likely plays an important role in the age-related impairment of skeletal 
muscle function by reducing power and speed of movement (Larsson et al., 1997). 
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Neural alterations could contribute to muscle weakness by reducing central drive to the 
agonist muscles or increasing coactivation of the antagonist muscles (Klass et al., 2007). 
Morse et al. (2004) reported the maximum activation of the plantar flexor muscles was 
lower in elderly males compared to young males (86% and 98% respectively) suggesting 
that the loss in muscle strength may partly be due to a reduced voluntary drive to the 
muscles. Muscles such as the tibialis anterior (Kent-Braun and Ng, 1999) and quadriceps 
(Roos et al., 1999) have shown no impairment of muscle activation with age. Roos et al. 
(1999) utilised the twitch interpolation technique and found there was no difference in 
the ability of. young and old groups to activate their quadriceps muscle (93.6% and 
95.5% respectively). In contrast a clear deficit in muscle activation has been reported in 
very elderly inactive adults (69-93% of full activation) (Harridge et al., 1999). 
2.3.8.2 Antagonist activation 
Greater co-activation can reduce the performance of agonist muscles both through the 
opposing action of the antagonist muscle and also by reciprocal inhibition (Crone and 
Nielsen, 1989). Several studies have found higher levels of co-activation of older adults 
during maximal voluntary efforts of various muscle groups: isometric knee extension 
(Izquierdo et al., 1999), elbow flexion and extension (Klein et al., 2001) and concentric 
knee extension (Izquierdo et aI., 1999). Contrastingly Klass et al. (2005) did not observe 
differences in co-activation during isometric contraction of the ankle dorsi flexors when 
comparing young and older groups. 
No definitive answer can be drawn from existing literature as to whether voluntary 
activation and co-activation during MVC is modified with ageing due to discrepancies 
ascribed to differences in physical condition, the muscle group that is tested and the type 
of contraction performed (Klass et al., 2007). 
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2.4 Falls 
The continual decline in muscle strength and power restricts locomotion and contributes 
to a loss of mobility and is a primary risk factor for falling (American Geriatrics Society, 
2001). Perry et al. (2007) found a falls group had 85% of the strength and 79% of the 
power of non-fallers for a range of lower limb muscle groups. Pijnappels et al. (2008) 
assessed how muscle strength influenced individuals' ability to deal with a gait 
perturbation that led to either falling or recovery of balance. Results showed that ankle 
and knee voluntary function measures (both maximum and rate of moment 
development), maximum leg press force, jump height, and grip strength were 
significantly lower for fallers compared to non-fallers. Therefore individuals who fall 
repeatedly (frequent fallers) or are less able to cope with gait perturbations have lower 
muscle function (strength and power) than non-fallers (Perry et al., 2007; Pijnappels et 
al., 2008). 
Falls are a major health issue for the ageing population. It is estimated that 30-50% of 
people over the age of 65 years of age experience at least one fall per year (Campbell et 
al., 1981), and about half of these will suffer recurrent falls (Masud and Morris, 2001). 
Falls frequently result in trauma, musculo-skeletal injury and disability. Approximately 
20% of falls require medical attention; 15% result in joint dislocations, soft tissue 
bruises, and concussions (Kannus et al., 1999). With ageing the skeleton becomes 
progressively weaker, therefore falling when bones are in a weakened state increases the 
likelihood of a fracture with 5% of falls resulting in fracture (Kannus et al., 1999). As 
. well as a high financial burden and morbidity falls typically contribute to decreased 
quality of life (Robbins et aI., 1989) and increased fear of falling, that leads to a 
reduction in activity and can cause a downward spiral of inactivity-related disability 
(Simey et al., 1999). 
Clearly there is a great need to investigate further how the factors influencing skeletal 
muscle strength and power impact upon the risk of falling. Genetic differences could via 
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their influence on factors such as sarcopenia and muscle fibre composition effect the 
predisposition of an individual to falling. 
2.5 Inheritance 
Heritability is the relative contribution of genetic and non-genetic factors to the total 
phenotypic variance in a population. Genetics is the study of genes, heredity, and the 
variation of organisms (World book encyclopedia, 1991). Heredity forms the basis of 
genetics. Modem molecular biology techniques have provided tools for investigating the 
function of specific genetic variants, and how they influence phenotype. Within 
organisms, genetic information is generally carried on chromosomes, where it is 
represented in the chemical structure of particular DNA molecules (Roth, 2007). Genes 
encode the information necessary for synthesizing the amino-acid sequences in proteins, 
which in turn play a large role in determining the final phenotype of the organism. 
Basically a gene is a segment of DNA which contains the information for making a 
protein; it codes for the nucleotide sequence in mRNA and rRNA that provides the 
information necessary to build a specific protein. Twenty to twenty five thousand genes 
exist within the human genome; although the complete list is still to be determined. The 
thousands of genes are found across all of the 22 autosomes, the X and Y chromosomes, 
and the mitochondrial genome, in locations specific to the gene. Nucleotide differences 
within the DNA sequence of a gene influences the function of that gene and therefore 
the protein synthesised, which results in an individual's specific phenotype or trait 
(Roth, 2007). Phenotype can be defmed as any observable or measureable characteristic 
or trait, and is typically determined by a combination of genetic and environmental 
factors. Genotype is the combination of 2 alleles, at a particular locus, present within a 
single individual, corresponding to the 2 alleles present on the paired chromosomes. 
Genotype also refers more generally to the genetic profile or genetic make-up of an 
individual. 
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Many traits, including health outcomes and behaviours, have a tendency to run in 
families, which share a similar environment but also genetic factors (Frederickson and 
Christeensen, 2003). During the past decade numerous studies have assessed the relative 
contribution of genetic factors to traits involved in physical functioning. Physical 
function and performance encompasses a number of phenotypes e.g. muscular strength 
and power, flexibility, balance, VOz max, blood pressure, body composition etc. Twin 
studies have provided evidence of a genetic contribution to a number of measures 
reflecting physical function. The heritability of muscle strength and power, the primary 
phenotypes of interest in this research, appears to be 30-80%, depending on the nature of 
the functional test employed (Thomis et al., 1998; Calvo et al., 2002). 
Thomis et al., (1998) assessed the quantification of genetic and environmental factors in 
arm strength in male monozygotic (MZ, N = 25) and dizygotic (DZ, N = 16) twins (22.4 
± 3.7 yrs). Variation in muscle phenotypes indicated a high contribution of genetic 
factors (Heritability) for isoinertial strength (0.77), isometric strength (0.69), and muscle 
cross-sectional area (0.85). Calvo et al. (2002) tested the heritability of anaerobic power 
and capacity in a group of 16 pairs (8 MZ and 8 DZ) of Caucasian male twins. Results 
revealed a high index of heritability (HI) for maximal 5 s power (HI = 0.74), mean 30 s 
power (HI = 0.84) and maximal lactate concentration (HI = 0.82) with the Wingate test. 
Carmelli et al. (2000) assessed the contribution of genetic influences to measures of 
lower-extremity function in 95 monozygotic (MZ) and 92 dizygotic (DZ), white male 
twins aged 68 to 79 years. The heritability of the lower-extremity performance was 57%. 
Tiainen et al. (2007) found genetic factors accounted for 52% of the variance in 
strength, 36% in power, and 34% in walking speed ofMZ and DZ female twins aged 63-
76 years. 
Recently the focus has moved toward the molecular level with studies of specific genetic 
factors using various approaches. The Human Gene Map for Performance and Health-
Related Fitness Phenotypes reports on advances in research of the relationship between 
gene variants and these phenotypes. The fitness and performance map includes 214 
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autosomal gene entries and quantitative trait loci, seven variants on the X chromosome, 
and 18 mitochondrial genes that have been quantitatively linked to fitness and 
performance phenotypes. The most up to date version of the map can be found in the 
review by Bray et al. (2009). Two candidate genes that have been suggested to have 
associations with a variety of physical performance phenotypes including muscle 
strength and power, and the physiological determinants of these phenotypes (e.g. muscle 
size and composition) are Angiotensin Converting Enzyme (ACE) and a Actinin-3 
(ACTN). 
2.6 Angiotensin Converting Enzyme (ACE) Gene Polymorphism 
A polymorphism within intron 16 of the ACE gene on chromosome 17q23 concerns the 
insertion (I allele) or deletion (D allele) of a 287 base alu repeat segment. Alu repeats are 
short segments of DNA interspersed throughout the genome, and is a member of the 
SINE (short interspersed' nuclear element) family of repeat elements (reviewed by 
Iasinska and Krzyzosiac, 2004). The alu repeat in the ACE gene is thought to have 
integrated into the ancestral human genome in the recent evolutionary past and has been 
found to be present at some frequency in almost every ethnic population that has been 
studied (see ALFRED: the ALelle FREquency Database for allele frequency data). The 
polymorphism results in the genotypes 11, ID, DD with representation among young 
healthy Caucasian persons - 24%, 50%, 26% respectively (Myserson et al., 1999). 
Intronic po1ymorphisms can have a phenotypic effect cumulative data show that introns 
are helpful symbionts of eukaryotic genomes that carry out various gene regulatory 
functions (Fedorova and Fedorov, 2003). These functions involve sources of non-coding 
RNA, carriers of transcription regulatory elements, actors in alternative and trans-
splicing, substrates for exon shuffling and signals for mRNA export from the nucleus 
(Fedorova and Fedorov, 2003). However it is possible that the ACE liD alle1es are not 
causal but are in linkage disequilibrium (that is not randomly segregating during 
intergenerational transmission) with other causal variants elsewhere or near ACE. 
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The entire functions of carrying the intron 16 alu on ACE expression is not known 
however studies have shown a greater effect of the D allele resulting in higher levels of 
serum ACE and tissue ACE activity (Rigat et al., 1990; Danser et al., 1995). Rigat et al. 
(1990) reported the liD polymorphism accounted for 47% of the total phenotype 
variance of serum ACE (11 = 299.3 ± 49 ~glL, liD = 392.6 ± 66.8 ~gIL, DD = 494.1± 
88.3 ~glL). Danser et al. (1995) reported cardiac ACE activity was higher in subjects 
with the ACE DD genotype (12.7 +/- 1.9 mU/g wet wt) compared with subjects with the 
ID (8.7 +/- 0.8 mU/g) and the 11 (9.1 +/- 1.0 mU/g) genotypes. 
2.6.1 Role of ACE within the Renin-Angiotensin-Aldosterone System (RAAS) 
Pathway 
The RAAS is a principal regulator of blood pressure and fluid homeostasis (Wang and 
Scherer, 2008). The major components are angiotensinogen, renin, Angiotensin I (ANG 
I) and Angiotensin 11 (ANG 11). 
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Figure 2.6 The Renin-angiotensin- aldosterone system (Author: A. Rad Date: February 2nd, 2006 
License: GFDL-selfCreated using XaraX') 
The RAAS pathway begins in the kidney when the juxtaglomerular cells in the afferent 
arterioles ofnephrons secrete an enzyme called renin. Renin converts an inactive plasma 
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protein angiotensinogen into ANG I. Angiotensin Converting Enzyme (ACE), a 
proteolytic enzyme, converts ANG I to the octapeptide ANG 11 and also inactivates 
bradykinin, an endothelium-dependent vasodilator that increases vascular permeability 
(Silverthom, 2004). Three roles of ANG 11 are: it is a potent vasoconstrictor that is 
important in the regulation of mean arterial blood pressure; it stimulates aldosterone 
, 
release from the adrenal cortex; and the release of ADH from the hypothalamus and 
therefore triggers the sensation of thirst (Germann and Stanfield, 2005). 
Aldosterone is a steroid hormone released from the adrenal cortex that regulates both the 
reabsorption of Na + and secretion of K+. It increases the number of sodium channels and 
potassium channels in the apical membrane by causing existing channels to open and by 
stimulating the synthesis of new channels (Germann and Stanfield, 2005). It also 
increases the synthesis of Na+/K+ pumps which increase the concentration of Na+/K+. 
Through these actions aldosterone increases sodium reabsorption and potassium 
secretion simultaneously (Germann and Stanfield, 2005). 
As previously mentioned studies have shown a greater effect of the D allele on serum 
ACE activity and tissue ACE with lower levels of the enzyme associated with the I 
allele. Theoretically higher serum ACE activity could enhance production of ANG 11, 
and it has been demonstrated that with ANG I infusion, plasma ANG 11 concentrations 
increase in DD compared to II subjects (Brown et al., 1998). Bradykinin is a 
nonapeptide that causes blood vessels to enlarge (dilate), and therefore causes blood 
pressure to lower. Bradykinin works on blood vessels through the release of 
prostacyclin, nitric oxide, and endothelial-derived hyperpolarizing factor (Germann and 
Stanfield, 2005). Kinins have shown to have growth inhibitory properties (McDonald et 
al., 1995). McDonald et al. (1995) showed that bradykinin antagonism inhibits the 
antigrowth effect of angiotensin converting enzyme inhibition in the dog myocardium. 
ACE degrades kinins and the extent of degradation is dependent on ACE activity 
(Campbell, 1994). Myerson et al. (2001) discovered that subjects with the ACE DD 
genotype experienced greater left ventricular hypertrophy after physical training 
compared with 11 genotypes that they attributed to possible lower kinin levels. 
33 
Chapter 2 
2.6.2 The physiology of ACE and ACE genotype within muscle tissues: potential 
influence on skeletal muscle phenotype? 
Apart from blood pressure regulation ACE may exert influences upon skeletal muscle 
through actions of ANG H and bradykinin as a consequence of higher ACE levels 
associated with the DD genotype. By using immunohistochemistry, ACE was detected 
in endothelial cells of capillaries in skeletal muscle (Schaufelberger et al., 1998). The 
number of ACE mRNA transcripts was related to muscle fibre area and an inverse 
relationship between the number of ACE transcripts and capillary density was also 
found. The close relationship between gene expression and capillary density in this study 
may suggest a role for the RAAS in modulating capillary growth in the skeletal muscle 
in humans. ANG II has also been found to be synthesised in skeletal muscle (Danser et 
al., 1995) and localized to the endothelial cells (Schaufelberger et al., 1998). ANG H 
appears to optimise skeletal muscle hypertrophy in response to overload (Gordon et al., 
2001). Gordon and colleagues showed that inhibition of endogenous ANG H production 
with an oral ACE inhibitor decreased rat plantaris and soleus muscle hypertrophy by 57 
and 96% respectively. 
Danser et al. (1995) assessed ACE activity in cardiac muscle which was significantly 
higher in subjects with ACE DD genotype (II = 9.1 ± 1.0 mu/g, ID = 8.7 ± 0.8 mu/g, DD 
= 12.7 ± 1.9 mu/g). Additionally Reneland and Lithell (1994) reported higher ACE 
activity within the vastus lateralis muscle associated with the D allele in 50 essential 
hypertensive subjects. Danser et al. (1999) investigated whether ACE genotype 
influenced production of ANG II in human leg muscle with infusion of ANG I. 
Production of ANG II within human leg muscle did not parallel with the D allele-related 
differences in ACE concentration. Additionally Lachurie et al. (1995) infused 
exogenous ANG I into muscle and despite the ACE genotype effect on serum ACE 
activity, genotype did not influence ANG II or plasma aldosterone production. Therefore 
it appears that ACE has no limiting influence on ANG H generation, so higher ACE may 
not necessarily result in higher concentrations of ANG H. 
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Ahmad et al. (2006) reported that ACE is the major cardiac enzyme involved in the 
degradation of bradykinin during a single passage through the coronary vascular bed of 
the healthy rat heart. Brown et al. (1998) tested the hypothesis that the ACE deletion 
allele is associated with enhanced degradation of bradykinin. ACE levels were increased 
in DD compared with II subjects. During ANG I infusion, plasma ANG II 
concentrations were increased in DD compared with II subj ects which, is contrary to the 
evidence presented by Lachuire et al. (1995) The half-life of bradykinin was 
significantly decreased in sera obtained from ACE DD compared with II subjects. 
Additionally there was a relationship between the half-life of bradykinin and serum ACE 
activity and between the half-life of bradykinin and the conversion of ANG I to ANG II 
confirming that ACE genotype determines bradykinin degradation. 
Ishigai et al. (1997) found that bradykinin significantly attenuated protein DNA content 
(which is an index of hypertrophy in heart cells) and it can work as an antihypertrophic 
substance in cardiomyocytes. Since the DD genotype is associated with higher serum 
ACE activity, individuals with the DD genotype may have lower kinins levels. It is 
therefore possible that DD individuals experience less protein degradation that could 
contribute to a greater net protein balance and synthesis. 
To date two published papers have considered the influence of ACE genotype on 
skeletal muscle fibre type composition. The possibility that the DD genotype maybe 
associated with a greater proportion of fast twitch fibres (Zhang et aI., 2003) could 
explain any association of the ACE D allele with strength/power, particularly at high 
velocities. Zhang et al. (2003) investigated the association between fibre type and ACE 
genotype. The DD genotype was associated with a greater proportion of fast twitch 
fibres, which supports the notion that the ACE D allele maybe associated with skeletal 
muscle function. Contrastingly Akhmetov et al. (2006) reported an increased frequency 
of the D allele (68.8% vs 34.4%) in 48 healthy young men with the highest proportion of 
slow-twitch fibers (56-70%) compared to the group with the lowest proportion (25-
43%). However, this article is written in Russian and only an Abstract is available in 
English. Finally, there is recent evidence that ACE genotype is associated with the 
muscle volume of healthy older men and women (Charbonneau et al., 2008) a key 
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determinant of muscle strength and power. Quadriceps muscle volume (MV) was 
measured by computed tomography (CT) in 86 men and 139 women. Higher MY was 
reported in male and female DD individuals compared to II individuals. 
2.6.3 ACE genotypes and athletic performance 
Over ten years ago Montgomery et al. (1998) described a genetic association that 
demonstrated an over representation of the I variant of the ACE gene in high altitude 
mountaineers. Their paper entitled the Human Gene for Physical Performance provided 
the impetus for many other groups to test the association of this polymorphism with 
various performance related phenotypes. 
Initially studies investigated the association of the I allele with endurance performance 
reporting that the frequency of the I allele was higher amongst endurance athletes 
compared to controls (Alvarez et al., 1999; Gayagay et al., 1998; Lucia et aI., 2005). 
Myerson et al. (1999) studied 79 Olympic standard runners ranging from ~200 m 
sprinters to ~5000 m endurance runners who were assessed for ACE genotype. Results 
showed a linear trend of increasing I allele frequency with distance run. A significant 
excess and skew toward the I allele was found in the 2:5000 m group, with a skew in 
favour of the D allele amongst sprinters (900 m). Similarly Nazarov et al. (2001) 
showed an excess of the D allele in short distance athletes in their study of 217 athletes 
(swimmers, skiers, triathletes and track-and-field participants) compared to 449 controls. 
An excess of the D allele amongst sprinters led Woods et al. (2001) to examine whether 
the ratio of I and D alleles in swimmers competing over different distances would vary. 
One hundred and twenty swimmers from the European and Commonwealth 
championships had their ACE genotype determined and their gene and allele frequencies 
compared with control groups. Of the 103 Caucasians, there was a significant excess of 
the D allele in elite swimmers compared to the control group. This association remained 
in those competing over shorter distances (400 m and below) but not in the longer 
events. 
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2.6.4 A CE genotype and skeletal muscle strength and function 
To date two reports have positively associated the ACE DD genotype with muscular 
strength (Table 2.1). Hopkinson et al. (2004) demonstrated that the D allele variant was 
associated with greater isometric quadriceps strength (P = 0.04) in a cohort of 103 
patients suffering from chronic obstructive pulmonary disease (Il = 31.4 kg; ID = 34.1; 
DD = 38.3). Williams et al. (2005) extended the fmdings of Hopkinson et al. (2004) to a 
young and healthy population. ACE genotype had a significant association with 
isometric strength (P = 0.026), with DD genotype individuals significantly stronger than 
ID or Il genotype individuals. Furthermore, ACE activity was positively correlated with 
both isometric and dynamic muscle strength. 
However the majority of work conducted is in contrast to the findings of Hopkinson et 
al. (2004) and Williams et at. (2005). Woods et al. (200Ib) reported no differences 
between ACE genotypes in the maximal voluntary force (MVF) of adductor pollicis 
(AP) in a cohort of 45 women. Furthermore two early studies found no association of 
ACE genotype with elbow flexor (Thornis et al., 2004) or Imee extensor (Folland et al., 
2000) isometric strength of healthy young men. However these studies involved small 
cohorts of <60 participants. 
In a much larger cohort (n=631) Pescatello et al. (2006) reported no ACE genotype 
association with isometric elbow flexor muScle strength of men and women. The large 
population was a strength of their study and could provide confidence in results, 
however the cohort had mixed ethnicity (Caucasian 80%, mixed origin 20%) and sex, 
which may have confounded the results. Likewise no genotype association with physical 
functioning strength in older persons was reported by Giaccaglia et al. (2008). The 
potentially stronger study by Frederickson et al. (2003b) comprising 684 older 
Caucasian males and females assessed isomeric hand grip strength. This study did not 
identify any genotype influence upon muscle strength. Moran et al. (2006) measured the 
influence of ACE genotype on hand grip strength in male and female Greek teenagers 
and again found no association in males and contrastingly reported greater hand grip 
strength in Il genotype females. Additionally in the largest cohort (n=2966) involving 
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older persons no genotype association with isokinetic knee extensor strength was 
reported by Kritchevsky et al. (2005). Conversely their population was quite 
heterogeneous comprising both males and females as well as mixed race and involved 
active and non active participants. The lack of a genotypic effect may have been 
confounded due to such heterogeneity. 
It is apparent that controversy surrounds the possible associations of ACE genotype with 
skeletal muscle strength and body composition. The mechanisms by which ACE 
genotype could be associated with skeletal muscle function seems plausible and case 
control studies suggest that there is a genotype connection with muscle function 
(Myerson et al., 1999; Nazarov et al., 2001). A number of studies have recognised the 
affect of the ACE D allele upon muscle phenotypes (Zhang et al., 2003; Charbonneau et 
al., 2008) as well as muscle strength (Williams et al., 2005; Hopkinson et al., 2004) 
however, the evidence to date provides no consensus. 
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Table 2.1 Association studies of ACE lID polymorphism with muscle strength 
Reference Strength Ethnicity N Difference 
SexlAge(yrs) beVween2enotypes 
Folland et al., Isometric & European 33 NS 
2000 isokinetic KE Caucasian (UK) 
M 18-30 
Woods et al., MVCofAP UK Caucasian 83 NS 
2001 F 60 
Frederikson et Hand grip Danes Caucasian 684 NS 
al., 2003 M&F73+ 
Thomis et al., Isometric & European 57 NS 
2004 concentric EF Caucasian 
torque M 22.4 ± 3.7 
Hopkinson et Isometric KE European 103P D allele associated 
al., 2004 Caucasian (UK) 101 C with> isometric 
M&F 64.1±9.1 P strength in P 
M&F 61.8±8.6 C NSinC 
Kritchevsky et Isokinetic KE USA 2966 NS 
aI., 2005 (60°'5') Caucasian &Black Active 
M&F & non 
70-79 active 
WiJliams et aI., Isometric & European 81 ACE DD was 
2005 isokinetic (1.05 Caucasian (UK) associated with> 
rads.s') KE M 22.2±3.9 isometric strength 
Pescatello et al., EF lRMand USA 631 NS 
2006 isometric 80% Caucasian 
M &F 24.2±O.2 
Moran et al., Hand grip Greek 1027 NS in males 
2006 M&F II females> 
11-18 handgrip strength 
Giaccaglia et Physical USA 231 NS 
al., 2008 functioning muscle M&F 
strength 60+ 
Charbonneau et KEIRM USA 86 NS 
aI., 2008 Caucasian& Black 139 
M&F 
50-85 
. . KE. knee extensors. EP, elbow flexors. AP, adductor poll,c,s. NS. nOn SIgnificant. P, pallent C. control . 
MVC, maximum voluntary contraction. 
39 
Chapter 2 
2.7 a Actinin-3 (ACTN3) R577X Polymorphism 
The ACTN 3 R577X polymorphism has been widely suggested to have an association 
with skeletal muscle composition, function and performance. The a actinins are a family 
of actin binding proteins related to dystrophin and the spectrins (Blanchard et al., 1989): 
ACTN1, ACTN2, ACTN3 and ACTN4. ACTNI and ACTN4 are non-muscle proteins 
(Kaplan et al., 2000), ACTN2 and ACTN3 are myofibrillar proteins located at the Z disk 
where they form a lattice structure. 
The ACTN3 gene situated on chromosome 11 q 14, encodes a protein constituent of the Z 
disk of myofibrils, and a polymorphism of this gene results in a loss of the ACTN3 
constituent. ACTN3 deficiency is due to homozygosity for a premature stop codon in 
ACTN3: C->T transversion at position 1,747 in exon 16, converting an arginine to a 
stop codon at residue 577 (R577X) resulting in the replacement of an· arginine (R), the 
normal functional allele, with a stop codon (X) at amino acid 577 (R577X) that negates 
the production of the functional ACTN3 protein (North et al., 1999). This polymorphism 
results in the genotypes RR, RX, XX with representation among healthy Caucasian 
Australian adults of 30, 52 and 18% respectively (Zhang et al., 2003). The frequency of 
the 577X null allele differs between human groups: it is -10% in African and 
approaches 50% in Eurasian populations (Mills et al., 2001). 
2.7.1 ACTN3 genotypes and athletic performance 
Numerous investigators have associated the ACTN3 polymorphism with elite athletic 
performance (Table 2.2). The first of these studies obtained DNA samples from a large 
group of elite Australian athletes and non-athletic controls (Yang et al., 2003). The 
frequency of the XX genotype was lower in power athletes than in controls and higher in 
female endurance athletes than controls. Additionally the power Olympians and female 
power athlete groups included no XX genotype individuals. It was suggested that the 
presence of the R allele of ACTN3 has a beneficial effect on skeletal muscle in 
generating forceful contractions at high velocities as ACTN3 protein could confer a 
40 
Chapter 2 
greater capacity for the absorption or transmission of force at the Z line during rapid 
contraction (Yang et ai, 2003). A similar study in Finnish athletes and controls also 
showed a marked decrease in the frequency of ACTN3 deficiency in sprint athletes and 
a slight increase in the frequency of the XX genotype in endurance athletes that was 
most apparent at elite level (Niemi and Majamma, 2005). Furthermore recent studies 
have reported that the frequency of the RR genotype has been found to be higher 
amongst elite strength (Roth et al., 2008) and power athletes (Druzhevskaya et al., 2008; 
Papadimitiou et al., 2008) compared to endurance runners or controls, indicating a 
beneficial effect on skeletal muscle function and in particular the ability to generate 
powerful contractions. These findings of an ACTN3 genotype association with athletic 
performance are consistent with the proposed mechanisms of ACTN 3 outlined below. 
Table 2.2 Case control studies of Acrn 3 polymorphism frequencies in elite athletes and controls 
Reference Discipline Ethnicity N Difference in 
SeX/Aee (Yrs) distribution 
Yang et aI., Elite from Australian 107 sprint & > freq. ofthe R allele in 
2003 14 sports Caucasian power sprinters than controls. 
M&F 192 endurance 
441 controls 
Niemi& Elite track & Finnish 52 endurance XX genotype> and RR 
Majarnaa, field 89 sprinters < in endurance athletes. 
2005 
Roth et al., Elite level USA 75 athletes < XX genotype freq. in 
2008 body Caucasian 876controls athlete's vs. controls. 
builders & Black 
strength M&F 
Druzhevskaya Power Russian 486 Athletes XX genotype < freq. in 
et al., 2008 oriented Caucasian Controls 1197 power athletes vs. 
M&F controls. 
17·24 
Papadimitiou Elite track & Greek Athletes > freq. of RR genotype 
et al., 2008 field Caucasian Controls in power athletes. 
Ahmetovet Endurance Russian &Tartars Athletes 456 Freq. of the XX 
al., 2009 Caucasian Controls 1211 genotype < endurance 
M&F athletes 
17·24 None ofthe highly elite 
athletes had the XX 
genotype 
Freq.,frequency. 
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2.7.2 ACTN3 genotypes and skeletal muscle strength andfunction 
Cross sectional association studies for the association of ACTN3 with muscle function 
are more equivocal, however (Table 2.3). Clarkson et al. (2005) studied the association 
between ACTN3 genotype and isometric and dynamic strength of men (n=247) and 
women (n=355). No genotype-muscle phenotype association was reported in men. 
However women homozygous for the ACTN3 X allele (XX) had lower isometric 
strength compared with heterozygotes (RR). It was concluded that 2.2% of the 
variability in isometric strength was attributable to ACTN3 genotype, and thus one of 
many genes contributing to the variation in muscle strength. A recent report investigated 
the association of ACTN3 RJX polymorphism with muscle fibre type and fast velocity 
knee extensor strength in a group of ninety healthy young men (18-29) (Vincent et al., 
2007). Homozygotes for the R allele showed higher relative dynamic quadriceps torque 
at 300°·s·' compared to XX carriers; additionally the number of type IlX fibres was 
greater in the RR than the XX genotype groups. 
In a more recent study Delmonico et al. (2007) reported XX genotype women had 
greater absolute peak power than RR and RX genotypes; this was not observed in the 
male population. An additional study by the same group reported no differences between 
genotypes when testing for knee extensor torque at 60°·s·' in men and women 
(Delmonico et al., 2008). Delmonico et al. (2008) recruited a mixed race cohort and 
although analysis was performed for each race their results contradicts their previous 
study. A large group of adolescent Greek male and females were genotyped and 
measured for grip strength and similar to the work of Delmonico et al. (2008) no 
genotype association with strength was observed (Moran et al., 2007). However, RR and 
RX genotype males had lower (faster) 40 m sprint times compared with XX genotype 
males and was not observed in the female cohort. 
42 
Chapter 2 
Table 2.3 Cross sectional studies of muscle strength according to ACTN3 genotype 
Reference Phenotype Population N Difference between 
Sex genotypes 
Aee (Yrs) 
Vincent et al., Isometric & Belgium 90 RR genotype individuals> 
2007 isokinetic 300··.-' M relative dynamic quadriceps 
KE strength 18-29 torque vs. with XX 
genotype. 
Clarkson et EF isometric USA 602 XX genotype women < 
al., 2005 (MVC)and Mixed ethnicity MVC vs. RR genotypes. 
dynamic l-RM M&F 
25 
Delmonico et KE concentric pp USA 157 XX genotype women> 
al., 2007 M&F absolute pp than RR & RX 
65 ± 8 NSinmen 
Delmonico et KE torque 60··s-' USA 1367 NS 
al., 2008 Caucasian&Black 
M&F 
79 
. Moran et al., Hand grip Greek 992 NS of hand grip strength 
2007 strength M&F RR & RX males faster 40m 
40m sprint 11-18 sprint times vs. XX. NS in 
females 
Walsh et al., KE torque 30 & USA 848 XX females < torque vs. RR 
2008 80°·s' M&F &RX 
22-90 NSinmen 
. . KE. knee extensors. EF, elbow flexors. PP, peak power. NS, non sIgnificant. l-Rm, 1 repetItIOn max . 
MVC, maximum voluntary contraction. 
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2.7.3 Physiological effects of ACTN3 genotype in skeletal muscle 
Studies of ACTN3 were originally motivated by the possibility that mutations in the 
ACTN3 gene might underlie muscle disease in humans (MacArthur and North, 2007). 
The complete absence had no obvious phenotypic effect and as outlined above the 
presence may have a more subtle association with muscle function. ACTN3 is found 
almost exclusively in the primarily anaerobic, glycolytic type IIX fibres (Mills et al., 
2001). The specialised expression pattern and strong sequence conservation of ACTN3 
over evolutionary time (North et al., 1999) suggests that this protein may possess some 
advantageous role in type 11 fibres. If this is the case then the absence of ACTN3 in the 
skeletal muscle may inhibit the performance of the type IIX fast glycolytic muscle fibres 
important for rapid powerful contractions (MacArthur and North, 2007) that anchors 
together actin-containing thin filaments and stabilises the contractile apparatus (Squire, 
1992). ACTN3 was also suggested to be functionally redundant (Mills et al., 2001) 
meaning that the function of one gene completely overlaps, but extends beyond that of 
another gene, as long as the gene whose function is completely overlapped performs the 
common function of the two genes more effectively (Krakauer and Nowak, 1999). This 
may be the case for ACTN2 and ACTN3 but ACTN3 performs the role in fast twitch 
fibres more effectively. 
The mechanistic actions of ACTN3 deficiency are currently being explored, and current 
knowledge is evolving rapidly. It is known that expression is restricted to type IIX 
muscle fibres and its presence is somehow beneficial for power and sprint athletes at an 
elite level (Chan et al., 2008). A number of hypotheses have been put forward. First, it 
may stabilize the sarcomere when mus~les are exercised to their maximum capacity, as 
in sprinting, and without ACTN3 the sarcomere may be weakened. This role is 
suggested due to the protein being located in the Z-disc and its actin binding properties. 
Second, ACTN3 may influence fibre type differentiation toward a fast twitch, glycolytic 
profile that is beneficial for sprint performance, with its absence leading to 
differentiation toward a slower oxidative profile that is beneficial for endurance 
performance (Chan et al., 2008). 
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Sarcomeric a actinins are known to interact with cell signaling proteins that are involved 
in fibre differentiation and with enzymes involved in metabolic pathways. It is therefore 
possible that ACTN3 could influence fibre type differentiation toward a fast glycolytic 
profile. MacArthur et al. (2007) reported that ACTN3 deficient muscle fibres mice had 
higher levels of oxidative enzymes that would be expected in a fast glycolytic fibre. 
MacArthur et al. (2008) revealed than the activity of oxidative enzymes was higher, and 
anaerobic enzymes were lower in KO mice than in wild types. Therefore ACTN3 may 
facilitate anaerobic metabolism, and its absence may promote more oxidative pathways. 
To determine if this alteration in skeletal metabolism affects performance MacArthur 
and North (2007) subjected ACTN3 deficient and ACTN3 sufficient mice to an 
endurance run and the XX mice performed significantly better that the RR mice running 
-33% further; suggesting that the shift toward oxidative metabolism increases intrinsic 
performance consistent with the over representation of the 577XX null genotype in 
endurance athletes (discussed above). Chan et al. (2008) reported features consistent 
with this hypothesis such as smaller cross sectional areas, lower twitch to tetanus ratios 
and better recovery from fatigue in ACTN3 deficient fibres in the mouse model. In the 
same study Chan et al. (2008) reported a 2.6 ms increase in the twitch half relaxation 
time of knockout mice compared with wild types which is consistent with the 
observation that elite sprinters have a very low incidence of ACTN3 deficiency. Lack of 
ACTN3 would appear to prolong the time taken for muscles to relax and therefore 
would be disadvantageous to activities requiring repeated rapid contractions such as 
sprinting (Allen et al., 1995). 
Additionally it is suggested that the a actinins form a hub at the intersection of several 
important functional pathways in skeletal muscle, helping to maintain the integrity of 
both the contractile apparatus and the crucial link between the sarcomere and plasma 
membrane, and potentially playing important roles in the communication between the 
sarcomeric machinery and other cellular pathways and the regulation of skeletal muscle 
metabolism (MacArthur and North, 2004). 
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Moreover, there is also recent evidence that ACTN3 genotype may have an association 
with fibre type composition in human skeletal muscle (Vincent et al., 2007). Muscle 
biopsies of the right vastus lateralis were obtained from 22 XX and 22 RR young men, 
analysis revealed the number of type IIX fibres was greater in RR than XX individuals 
and ACTN3 protein content was systematically higher in type IIX compared to type IlA 
fibres. These authors suggested that the mechanism by which ACTN3 has its effect on 
muscle power may partly rely on the regulation of fibre type proportions. Norman et al. 
(2009) obtained muscle biopsies from the vastus lateralis muscle of 21 men to determine 
fibre type composition and ACTN3 mRNA levels. In contrast to Vincent et al. (2007) 
fibre type composition across the 3 genotypes did not differ suggesting that ACTN3 do 
not play a significant role in detennining muscle fibre type composition. Norman et al. 
(2009) additionally showed that ACTN2 expression is affected by the content of CL 
actinin-3, which implies that CL actinin-2 may compensate for the lack of CL actinin-3 and 
hence counteract the phenotypic consequences of the deficiency. 
ACTN3 has also been proposed as a candidate metabolically 'thrifty gene' (Neel, 1962), 
with the absence of ACTN3 hypothesised to improve energetic efficiency (Mc Arthur 
and North, 2004) that could promote energy storage and body fat accumulation. 
However there has been little support for this in young people (Vincent et al., 2007). 
Vincent et al. (2007) did not observe differences between genotypes for body fat 
percentage, fat mass and fat free mass (FFM) in ninety young Belgium males using 
bioelectrical impedance. Moran et al. (2000) reported similar results of no genotype 
influence on BMI and skinfold measures in their group of young athletes. In mouse 
models however Chan et al. (2008) reported ACTN3 deficient mice displayed lower lean 
mass and total body mass. It is possible that an effect may only accrue over the human 
lifespan and a subtle genetic association with energy balance may only become apparent 
over a prolonged period of several decades. 
Considering the evidence that ACTN3 may perform important functions in type 11 
skeletal muscle, it seems reasonable to assume that there may be subtle differences in 
skeletal muscle function between humans with different ACTN3 genotypes. The 
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apparent benefit for the presence of functional ACTN3 in elite sprint/power performance 
is consistent with the localisation of ACTN3 to skeletal muscle type II fibres and the 
overrepresentation of the functional allele among elite sprinters. 
It has been suggested that the presence or absence of ACTN3 in humans has functional 
implications only in certain environments or under extreme conditions, which could be 
why the frequency of functional ACTN3 is shown to be abundant in elite level sprint and 
power athletes compared to the normal population (Neimi and Majamaa, 2005; Yang et 
al; 2003). 
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CHAPTER 3 
ACE lID and ACTN3 R577X Polymorphisms and Human Muscle 
Functional 
and Contractile Properties in Young Caucasian Men. 
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3.1 Introduction 
Genetic factors are thought to determine 20-80% of the variation in a number of traits 
important to athletic performance (MacArthur & North, 2007) for example the relative 
proportion of fast and slow twitch skeletal muscle fibres (Simoneau and Bouchard, 
1995; - 45% due to inherited factors). The annual publication of the human gene map 
for performance and health related fitness phenotypes (Rankinen et al., 2006) lists more 
than ISO genes or genetic regions associated with athletic performance and physical 
fitness traits. The angiotensin converting enzyme (ACE) liD polymorphism (Williams et 
al., 2005) and a. actinin 3 (ACTN3) R577X polymorphism (Mills et al., 2001) have 
recently been identified as potentially contributing to variations in skeletal muscle 
composition, function and performance. 
The ACE gene has been the most extensively studied gene in the area of human 
performance phenotypes. A functional polymorphism of the ACE gene is defined as the 
presence (insertion, I allele) or absence (deletion, D allele) of a 287 amino acid base pair 
Alu repeat sequence within intron 16 of the ACE gene on chromosome 17 (Rigat et aI., 
1990). The polymorphism results in the genotypes 11, ID, DD with representation among 
white European adults of approximately 24%, 50% and 26% respectively (Myerson et 
al., 1999). A high proportion of the DD genotype has been reported in elite sprint 
athletes compared with endurance athletes and controls (Myerson et al., 1999; Woods et 
al., 2001; Nazarov et al., 2001), indicating that this genotype may be associated with 
skeletal muscle function. 
ACE is recognised as a key enzyme in the renin-angiotensin system and it has been 
shown that the D allele variant of the ACE gene is associated with higher concentrations 
of serum ACE activity (Rigat et al., 1990). ACE catalyses the production of ANG 11, 
which appears to enhance skeletal muscle hypertrophy (Gordon et al., 2001; 
Westerkamp and Gordon, 2005). Additionally ACE degrades kinins (Brown et al., 
1998), which have been shown to have growth inhibitory properties (Ishigai et al., 
1997). There is recent evidence that ACE genotype is associated with the muscle volume 
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of healthy older men and women (Charbonneau et al., 2008) a key detenninant of 
muscle strength and power. Fascinatingly Zhang et al. (2003) reported that the DD 
genotype was associated with a greater proportion of fast twitch fibres in a Japanese 
population. This evidence supports the notion that the ACE D allele may be associated 
with skeletal muscle function particularly strength/power at high velocities. However, in 
contrast Akhmetov et al. (2006) reported that the DD genotype was associated with a 
greater proportion of slow twitch fibres in a Russian population. 
Several investigations have found no association of ACE genotype with isometric and 
dynamic strength (Folland et al., 2000; Thomis et al., 2004; Woods et al., 2001; 
Pescatello, et al., 2006). Although the D allele has been associated with greater isometric 
strength in COPD patients (Hopkinson et al., 2004) and isometric and isokinetic strength 
in healthy young men (Williams et al., 2005). To date no studies have examined the 
association of ACE genotype with high velocity strength and the contractile properties 
of human skeletal muscle which is of great interest given the potential association of 
ACE genotype with fibre type composition. 
u actinins are a family of actin-binding proteins found in humans (Blanchard et aI., 
1989): ACTNl and ACTN4 are non muscle proteins (Kaplan et al., 2000) whereas 
ACTN2 and ACTN3 are myofibrillar proteins located at the Z disk where they form a 
lattice structure that anchors together actin containing thin filaments and stabilises the 
contractile apparatus (Squire, 1992). The functions of ACTN3 are likely to involve a 
static function in maintaining the ordered myofibrillar array (Mills et al., 2001). A 
common genetic variation in the ACTN3 gene results in the replacement of an arginine 
(R) with a stop codon (X) at amino acid 577 (R577X). The 577R allele is the normal 
functional allele of the gene, whereas 577X allele contains a sequence change that 
negates the production of the functional ACTN3 protein (North et al., 1999). This 
polymorphism results in the genotypes RR, RX, XX with representation among healthy 
white Australian adults of30%, 52% and 18% respectively (Yang et al., 2003). 
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ACTN3 is found almost exclusively. in the primarily anaerobic, type II fibres (North and 
Beggs, 1996). The specialised expression pattern and strong sequence conservation of 
ACTN3 over evolutionary time (North et al., 1999) suggests that this protein may 
possess some advantageous role in type II fibres. The absence of ACTN3 in the skeletal 
muscle has been suggested to inhibit the performance of the type II muscle fibres that 
are important for rapid powerful contractions (MacArthur and North, 2007). Moreover, 
there is also recent evidence that ACTN3 genotype may be associated with fibre type 
composition (Vincent et al., 2007). 
It has been demonstrated that the frequency of the ACTN3 RR genotype was higher 
amongst elite sprinters compared to endurance runners (Niemi and Majamaa, 2005) or 
controls (Yang et al., 2003) while none of the top sprinters harboured the XX (ACTN3 
deficient) genotype. This suggests that the presence of ACTN3 may have a beneficial 
effect on skeletal muscle function and in particular the ability to generate powerful 
contractions at high velocity. 
Interesting reports have highlighted an apparent association of ACE and ACTN3 
genotypes with sprint performance. The association of these polymorphisrns with the 
contractile properties of human muscle and with strength throughout the torque velocity 
relationship has not been investigated. The purpose of this study was to carry out a 
comprehensive assessment of knee extensor muscle function and contractile properties 
in relation to the ACE IID and ACTN3 RlX polymorphisrns in healthy young men, and 
in particular their association with muscular strength at high velocities. 
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3.2 Methodology 
3.2.1 Participants and anthropometric assessment 
Ethical approval for this study was provided by the Loughborough University ethical 
advisory committee. The study was performed according to the Declaration of Helsinki. 
Seventy-nine UK Caucasian males, aged 18-30 years, volunteered to participate in this 
study and provided written informed consent. Participants were recruited from amongst 
University students, had no history of strength training, moderate-Iow overall physical 
activity «4 sessions of exercise per week) and were free from locomotor or 
neuromuscular disease. 
Participants' height was measured with a wall-mounted stadiometer (Holtain Ltd, 
Crymych, Wales) and body mass with a beam balance scale (Avery Ltd, Fairmont, MN) 
whilst participants wore shorts and aT-shirt. Skinfold thickness was measured at four 
sites (biceps, triceps, suprailiac and subscapular) using Harpenden skinfold calipers 
(British Indicators Ltd, Wolverhampton, UK). The measures were taken on the right side 
of the body and repeated 3 times, in order to calculate an average value. From the sum of 
four skinfolds body density was calculated using the formula of Durnin and Womersley 
(1974) and percentage body fat estimated using the Siri equation (Siri, 1956). Fat mass 
and fat-free mass (FFM) were derived from the percentage body fat and body mass 
values. 
3.2.2 Protocol overview 
Participants were tested between the hours of 1400 and 1800 and were asked to refrain 
from heavy physical exertion in the 36 hours prior to measurement. Prior to strength 
assessment participants performed a warm up of 5 minutes on a cycle ergometer 
(Monark 8I8e) at -50 W. A range of muscle function tests were performed on the knee 
extensors. All tests were performed on both legs and were completed on two separate 
occasions with at least 72 hours separating each laboratory visit. Values from both legs 
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measured on each occasion were averaged to provide representative values for each 
individual. Participants were given verbal encouragement on all tests. 
3.2.3 Knee extensor isometric strength and contractile properties 
Both voluntary and electrically stimulated isometric contractions of the knee extensors 
were assessed using a conventional isometric strength testing chair (Parker et al., 1990) 
where participants were seated in an upright position with the back supported, and knee 
and hip joint angles at 90· (1.57 rad) and 80· (1.41 rad), respectively. Participants were 
finnly secured with straps, which fastened at hips and shoulders. Participants lower leg 
was tightly strapped, approximately 2 cm above the ankle, to a calibrated U-shaped 
alurninum strain gauge (Jones and Parker, 1989) that was always in the direct line of 
action of the applied force. The strain gauge signal was sampled at 2,000 Hz with an 
analogue to digital (ND) converter (Micro 1401, Cambridge Electronic Design Ltd, 
Cambridge, UK) and logged and displayed by PC with Spike 2 software (Cambridge 
Electric Design Ltd, Cambridge, UK). 
Following some progressive sub-maximal contractions maximum isometric strength was 
determined by having participants perform 3-4 maximum voluntary contractions of the 
knee extensors, each of -3 s duration and with 30 s rest between each contraction. The 
highest value was recorded as the participants' maximum strength. The coefficient of 
variation (CV) for maximum isometric strength over repeated test occasions was 3.3%. 
The contractile properties of the knee extensors were measured using electrically 
stimulated contractions. The participants remained seated in the chair and 2 large (13 x 
10 cm) flexible carbon rubber electrodes (Electro Medical Supplies Ltd, Wantage, UK), 
coated with electrode gel (Camcare Gels, Ely, UK) were placed over the anterior surface 
of the muscle. Percutaneous electrical stimulation with unidirectional square wave 
pulses of 50 flS duration was applied through a constant current Digitimer stimulator (DS 
7AH, Welwyn, Garden City, UK). The stimulation current began at 5 mA and gradually 
increased until the twitch response reached a plateau of maximal twitch force. The 
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twitch response was filtered by applying a digital filter with a low pass frequency of 30 
Hz and a transition gap of 16 Hz. Semi automated cursors within the spike 2 software 
were used to identify discrete events within each twitch. Time to peak tension (TPT) was 
taken as the time between force onset and peak twitch force, with force onset defined as 
3% of peak gradient. Half relaxation time (HRT) was the time for the muscle to relax 
from peak twitch force to half peak force. The peak rate of force development 
(PeakRFD) during the twitch was assessed as the maximum gradient of the force-time 
graph. Three twitches were analysed, the average values were recorded for each leg. The 
coefficient of variation (CV) for TPT, HRT and RFD over repeated test occasions was 
6.8, 13.8 and 8.7 % respectively. 
3.2.4 Torque-velocity relationship 
For torque measurements participants were seated in a Cybex Norm Isokinetic 
Dynamometer (Lumex Inc, NY, USA) with the axis of the knee joint aligned with the 
centre of rotation of the dynamometer arm, and the lower leg strapped to the lever arm 
just proximal to the ankle. Participants were restrained at the waist, shoulders and the 
distal part of the thigh, and the backrest was set at 100° (1.73 rad) from the horizontal 
base of the seat. Peak torque of the knee extensors was assessed isometrically at 73° 
(1.27 rad) of knee flexion (identified by pilot work as the angle of peak torque) and 
isokineticallyat 30, 90 and 2400 ·s·1 (0.52, 1.57,4.19 rad.s· I). The relative torque at high 
velocity (ratio of strength at 2400 ·s·1 to 300 ·s·1 (4.19:0.52 rad·s· I)) was calculated as a 
percentage. For isometric measurements there were 3 practice contractions at 50% effort 
followed by 3 maximum voluntary contractions. For the isokinetic measurements 
participants performed a set of 3 practice trials of sub-maximal knee extension at each 
angular velocity, prior to 2 sets of 2 maximum contractions at 300 ·s·1 and 2 sets of 3 
maximum contractions at 900 ·s·1 and 2400 ·s·l • There was at least 30 s rest between each 
set of contractions, and -60 s between velocities. The range of motion for the isokinetic 
measurements was from 120° - 15° (2.09 - 0.26 rad) of knee flexion. Knee extensor 
torque values were corrected for gravitational torque, and contractions at the highest 
velocity 2400 ·s·1 (4.19 rad·s·l ) were typically isovelocity for at least the range 90° - 30° 
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(1.57-0.52 rad). The CV for the different torque measurements over repeated test 
occasions was from 5.3-6.3%. 
3.2.5 Blood collection and genotyping 
A trained phlebotomist perfonned venous puncture. Participants lay in a semi - supine 
position whilst a 10 rnl blood sample was obtained from a superficial foreann vein 
following a 12 hour fast to avoid lipemic sera. Blood samples were collected in a serum 
tube and applied onto filter paper in preparation for genomic deoxyribonucleic acid 
(DNA) isolation. All blood samples were left at room temperature for 2-3 hours to allow 
blood to clot. The samples were then spun at 2300 revs·min'! (rpm) for 10 minutes at 4°C 
in a refrigerated centrifuge (Beckman Instruments, Palo Alto, CA) and stored at -20°C 
enabling the determination of serum ACE activity on a separate occasion. 
Genomic. DNA was obtained from previously bloodstained filter paper using Chelex 
extraction and genotypes for the polymorpisrns of ACE IID and ACTN3 RIX were 
determined. ACE IID polymorphism was typed using polymerase chain reaction (PCR) 
based amplification. The final reaction mixture of 15 /-11 for ACE contained: ACE 
Forward and Reverse Primers at 0.3 /-11 each, 5 /-11 chelex extraction DNA, 7.5 /-11 
2xReddy mix (ABgene) which contained 1.25 units Thennoprime Plus DNA 
Polymerase, 75 mM Tris-HCI, 20 mM(NH4)2S04, 2.5 mM MgCb, 0.01 % (v/v) Tween® 
20 and 0.2 mM each of dATP, dCTP, dGTP and dTTP and precipitant and red dye for 
electrophoresis and 1.9 /-11 H20. Mistyping of ID heterozygotes' has been found in some 
studies to occur due to preferential amplification of the D allele, and inefficiency in the 
amplification of the I allele. To increase the specificity of DD genotyping, PCR 
amplifications were also perfonned with an I-specific primer pair 
(5' TGGGACCACAGCGCGCCCGCCACTAC3' and 
5'TCGCCAGCCCTCCCATGCCCATAA3') in all the samples that were found to be 
DD after amplification with the flanking primers. Briefly I specific amplification was 
perfonned using 25 fll reaction with I min denaturation at 94°C, followed by 30 cycles 
of 30 s at 94°C, 45 s at 67°C (annealing), and 2 min at noc (extension). The 335bp 
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fragment was identified on 2% agarose gel containing ethidium bromide. Under these 
conditions only the I allele produces a 335bp amplicon. The reaction yielded no products 
in a sample of all the DD genotypes. 
ACTN 3 polymorphism was typed using PCR. The final reaction mixture of 20 III for 
ACTN 3 contained: ACTN3 Forward and Reverse Primers at I III each, 10 III of 2x 
Readdy Mix, (5 mM MgCb) (ABgene), 5 III chelex extracted DNA and 3 III H20. The 
PCR reaction conditions protocol (Table 3.1) was programmed onto and run on 
Mastercycler PCR machine (Eppendorf, Hamburg, Germany). 
Table 3.1 Forward and reverse primers and PCR conditions for ACE and ACTN3 
Forward Primer Reverse Primer 
(5'-3') (5'-3') PCR reaction conditions 
Initial Denaturation (D) Final 
Denaturation Annealing (A) Extension 
Extension (E) 
CTGGAGACCACT GATGTGGCCATC 95'Cfor5min 30cyclesof n'Cforl Omin 
CCCATCCTTTCT ACATTCGTCAGAT 95'Cforlmin (D), 58'Cforlmin (A), 
n'Cfor2 min (E) 
35cyclesof 
ACTN3- CTGTTGCCTGTG TGGTCACAGTATG 95'Cfor5mins 95'Cfor30sec (D), n'CforlOmin 
GTAAGTGGG CAGGAGGG 60'Cfor30sec (A), 
16 n'Cfor30sec (E) 
PCR product (15 Ill) for ACE was then analysed by electrophoresis at 140 V for 45 
minutes through a 2% agarose gel containing 0.5 J.1g/ml ethidium bromide and IxTris-
borate, ethylenediaminetetraacetic acid (EDT A) electrophoresis buffer pH 8.3 (TB E). 
Additionally, 5 III of 100bp ladder (Abgene) was loaded to identify 190 and 490bp 
fragments for the ACE I/D polymorphism. A UV transilluminator (UVP, Cambridge, 
UK) was then used to visualize and score DNA fragments. 
Following genomic DNA amplification, ACTN3 PCR product was digested using Ddel 
restriction enzyme (New England, Biolabs Inc., Ipswich, MA) at 37°C for 4 h 
(Mastercycle, Eppendorf). The reaction mixture of 20lll contained: 0.41l1 Enzyme Ddel, 
2 III of lOx NEBuffer 4 (PH 7.9 at 25°C) constituting of 50 mM potassium acetate, 20 
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mM Tris-acetate, 10 mM magnesium acetate and 1mM dithothreitol, 0.2 III 100x bovine 
serum albumin (BSA), 7.6 III H20 and 10 III ACTN3 PCR product. The recognition site 
for the DdeI restriction enzyme was CTNAG (5'-3'). 
PCR product (15 Ill)for ACTN3 was then analysed by electrophoresis at 120 V for 90 
minutes through a 3% agarose gel containing 0.5 Jlg/ml ethidium bromide and 1xTris-
borate, ethylenediaminetetraacetic acid (EDTA) electrophoresis buffer pH 8.3 (TBE). 
Additionally, 5 III of 100bp ladder (Abgene) was loaded to identify 86, 97, 108 and 
205bp fragments distinctive of the ACTN3 polymorphism. A UV transilluminator 
(UVP, Cambridge, UK) was then used to visualize and score DNA fragments. 
3.2.6 Serum A CE activity 
Diagnostic determination of ACE activity in serum was carried out by an enzymatic 
assay using an automated spectrophotometer (Cobas Mira Plus, Roche, Switzerland). 
The enzyme mediates the cleavage of a synthetic substrate and the kinetics of this 
cleavage reaction are measured following the decrease in absorbance at 340 nm. This 
was measured twice with the Biihlmann ACE kinetic kit (Biihlmann Laboratories AG, 
SchOnenbuch, Switzerland). The intra-assay coefficient of variation for the serum ACE 
measurements was 4.9%. 
3.2.7 Statistical analysis 
A Chi squared test was used to confmn that the observed frequencies for ACE and 
ACTN3 were in Hardy-Weinberg Equilibrium. All data was confmned as normally 
distributed using SPSS for windows 12.0 (SPSS, Chicago, IL). A one way analysis of 
variance (ANOVA) was used to test the differences in strength, contractile properties 
and serum ACE activity between ACE IID and ACTN3 RIX genotypes. A Pearson's 
product moment correlation was used to examine the relationship between serum ACE 
activity and the functional and contractile properties of the knee extensors. Statistical 
analyses were performed using SPSS for windows 12.0 (SPSS, Chicago, IL) and 
Microsoft Excel 2000 for windows (Microsoft, Redmond, WA). Data are presented as 
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mean and standard deviation of the mean (SD) with statistical significance defined as P 
values of < 0.05. 
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3.3 Results 
3.3.1 Physical characteristics 
A total of 79 participants were studied, whose characteristics were (mean ± SD): age, 
20.1 ± 2.2 yr; body mass, 75.3 ± 11.1 kg; height, 1.79 ± 0.06 m; body mass index, 23.2 ± 
3.9 kg·m·2; FFM 57.1 ± 8.4 kg. The distribution of ACE ( II = 17, ID = 40, DD = 22) and 
ACTN3 (XX = 15, RX = 37, RR = 27) genotypes were in Hardy-Weinberg equilibrium. 
Physical characteristics were independent of ACE and ACTN3 genotypes. 
3.3.2 ACE lID polymorpllism, serum ACE activity and knee extensor functional and 
contractile properties 
No differences existed between ACE genotypes for knee extensor isokinetic torque at 
any velocity from O··S·I - 240··s·1 (ANOV A, 0.12 < P < 0.23; Figure 3.1a) or the relative 
torque at high velocity (240:30··s·\ II 59 ± 5, ID 59 ± 6, DD 59 ± 5 %; ANOVA, P = 
0.971; Figure 3.2). No differences existed between ACE genotypes for the time course 
of the twitch (TPT, ANOVA, P = 0.135; HRT, ANOVA, P = 0.312; Figure 3.3a) or 
peak RFD (ll 4678 ± 1654; ID 4535 ± 1189; DD 4611 ± 1226 N·s· l ; ANOVA, P = 0.86). 
There was no significant difference in isometric strength between ACE genotypes (ll 
600 ± 88; ID 632 ± 89; DD 577 ± 86 N; ANOVA, P = 0.07; Figure 3.4). Serum ACE 
activity for the whole group was 53 ± 22 U/L, and this was significantly influenced by 
ACE genotype (ll 30 ± 11; ID 55 ± 22; DD 66 ± 16 U/L; ANOVA, P < 0.01). Serum 
ACE activity was not associated with any functional measurement (isometric strength R 
= 0.11, P = 0.33; isokinetic strength at 30··s·1 R = 0.16, P = 0.18; isokinetic strength 
30··s·1 R = 0.06, P = 0.62). 
3.3.3 ACTN3 R577X polymorpllism and knee extensor functional and contractile 
properties 
No differences existed between ACTN3 genotypes for knee extensors isokinetic torque 
at any velocity from O··S·I- 240··s·1 (ANOVA, 0.64 < P < 0.99; Figure 3.1b) or the 
59 
Chapter 3 
relative torque at high velocity (240:30°·s·'; RR 60 ± 6, RX 58 ± 4, XX 60 ± 6 %; 
ANOVA, P = 0.19; Figure 3.2). No significant differences existed between ACTN3 
genotypes for the time course ofthe twitch (Figure 3.3b) or peak RFD (RR 4493 ± 1241; 
RX 4748 ± 1344; XX 4611 ± 1226 N·s·'; ANOVA, P = 0.65). Isometric strength was 
independent of ACTN3 genotype (RR, 599 ± 81; RX, 619 ± 92; XX, 606 ± 103 N; 
ANOVA, P = 0.66; Figure 3.4). 
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Figure 3.1 ACE (A) and ACTN3 (B) genotype were not significantly associated with isokinetic torque. 
Data presented as mean values (n = 79). 
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Figure 3.2 ACE and AC1N3 genotype were not associated with the relative torque at high velocities. 
Values are presented as mean and SD (n = 79). 
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Figure 3.3 Contractile properties were not significantly associated with ACE (A) and AC1N3 (B) 
genotype. Values are presented as mean and SO (n =79). 
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Figure 3.4 Isometric strength according to ACE and AC1N3 genotypes. Data are mean and SO (n=79). 
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3.4 Discussion 
The aim of this study was to evaluate the association of ACE lID and ACTN3 RIX 
polymorphisms on knee extensor muscle function and contractile properties of healthy 
young men. Specifically it examined the association of two candidate gene 
polymorphisms with muscle strength at high velocities as well as the time course of an 
electrically stimulated twitch. ACE lID and ACTN3 RIX polymorphisms were not 
associated with muscular strength at high velocities or the time course of the twitch 
response. 
The strength values recorded in this experiment were typical of untrained healthy young 
men (Folland et a!., 2000; Folland et al., 2005). Every effort was made to ensure that the 
participants made genuinely maximal contractions, and the reliability of the 
measurements was generally high (CV: 3.3% for isometric force; 5.3-6.3% for torque 
measurements; 5.8% relative torque at high velocity; 6.8% TPT; 13.8% HRT; 8.7% peak 
RFD). We endeavored to avoid the potentially confounding effects of chronic physical 
training and ethnic diversity in order to highlight the association of genes with strength. 
Therefore we recruited volunteers with moderate to low levels of physical activity, 
which likely explains the wide variation in body composition, as well as ensuring 
participants were UK Caucasian. 
Dynamic strength and power are critical aspects of muscle function that have greater 
validity for sports performance and health (general mobility and locomotion) than 
isometric strength measurements. Hence the importance of identifying genetic variations 
which influence dynamic strength and power. The current study was the first to examine 
the association of ACE genotype with the torque-velocity relationship and the time 
course of a twitch response. It was thought that if the DD genotype is associated with a 
greater proportion of fast twitch fibres then this could be associated with muscle 
function, particularly torque at high velocity and the time course of the twitch response. 
However ACE genotype was not associated with the absolute or relative torque at high 
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velocities or the timecourse or RFD of a maximal twitch response, and in the current 
study had no association with muscle function. The relative torque at high velocity 
(240:30·.s· l ) that we have calculated is also thought to be a functional indicator of fibre 
type (r = 0.74 with the relative area oftype II fibres; Gur et al., 2003). Whilst it is clearly 
not a direct measure of isoform profile a growing body of evidence suggests that the 
ratio of muscle torque produced at fast versus slow speeds is highly correlated to the 
area and isoform profile of muscle fibres (Gur et al., 2003; Ivy et al., 1981; Suter et al., 
1993). The TPT has also been found to reflect the percentage of type II fibres (Hamada 
et al., 2000; Edwards et al., 1976). 
Zhang et at. (2003) reported individuals with DD genotype had a greater proportion of 
fast twitch fibres in a Japanese population. This evidence supports the notion that the 
ACE D allele may be associated with skeletal muscle function particularly 
strength/power at high velocities. However, a recent contrasting study of Russian men 
found ACE D allele carriers to have a higher proportion of slow twitch fibers 
(Akhmetov et al., 2006). Our results demonstrate that there is either no association of 
ACE genotype with fibre type composition or the effect is too small to show association 
with the muscle function ofUK Caucasian men. 
In keeping with the literature, ACE genotype was associated with circulating ACE 
activity (Rigat et al., 1990). Whilst it has previously been reported that circulating ACE 
activity is associated with muscular strength (Williams et al., 2005), in the current study, 
there was no association of ACE activity with any measure of muscle function. 
Furthermore, we found no association of ACE genotype and muscle function. A similar 
recent study by Williarns et al. (2005) reported a significant effect of ACE genotype on 
isometric and isokinetic strength at 1.05 rads·s·1 in 81 Caucasian men. The current 
investigation and that of Williams et al. (2005) studied very similar subject populations 
and functional measurements. Therefore it is difficult to account for the contrasting 
findings. The lack of an ACE genotype association with isometric strength in the current 
study is similar to previous findings (Folland et al., 2000; Frederiksen et al., 2003; 
Thomis et al., 2004; Pescatello et al., 2006; Hopkinson et al., 2004). It is increasingly 
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recognized, with evidence from a number of studies, that an individual gene has, at best, 
a small association with physical function (Williams and Folland, 2008). This may 
explain the contrasting findings from single gene studies, and in part motivated this 
attempt to quantify the simultaneous influence of two candidate genes upon a specific 
phenotype (muscle function). As -20-80% of the phenotypic variation appears to be due 
to inherited factors it is likely that numerous as yet unidentified genes collectively 
influence muscle function (Williarns and Folland, 2008). 
The other candidate gene considered in this study was the ACTN3 RIX polymorphism 
which, was not associated with the absolute or relative torque at high velocities or the 
twitch response. This is surprising giving the apparent role that ACTN3 may play in fast 
twitch fibers and the suggested advantageous effect on skeletal muscle function 
particularly the ability to generate powerful contractions at high velocity (Yang et al., 
2003). Although, in older women (64 yrs) knee extensor concentric peak power was 
found to be higher in X allele homo zygotes compared to RR genotype individuals 
(Delmonico et al., 2007). In contrast to the current study and Delmonico et al. (2007), 
another recent study reported higher relative dynamic torque at 3000 ·s·1 for RR genotype 
individuals compared to XX carriers (Vincent et al., 2007). Fiber type differed 
significantly between the homozygote genotypes of Vincent et al. (2007), with the 
percentage surface area and number of type IIX fibres being greater in the RR than the 
XX genotype group. The velocity used in the current study was 2400 ·s·1 compared to the 
3000 ·s·1 used by Vincent et al. (2007). A higher velocity of torque measurement may 
more effectively discriminate for fibre type differences between genotypes. 
Isometric strength of the knee extensors was not associated with ACTN3 genotype in 
our cohort. Similarly Clarkson et al. (2005) reported no association between ACTN3 
R577X genotype and muscle phenotype in men when investigating isometric elbow 
flexor strength although these authors reported that women homozygous for the ACTN3 
577X allele (XX) had lower isometric strength compared with heterozygotes (RX). 
Whilst the current study found no association of the two candidate genes considered 
with muscle function phenotypes of young men, it is feasible that they may be associated 
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with the muscle function of other populations e.g. women, patient groups or older 
individuals. For example a gene-environment interaction could occur over several 
decades, and accelerate or delay the decline in function with age. 
To conclude, in the present study ACE IJD and ACTN3 RIX polYmorphisms were not 
associated with muscular strength at high velocities or the time course of the twitch 
response. Any association of these individual polymorphisms does not appear to be of 
sufficient magnitude to influence muscle function in young free living UK Caucasian 
men. It remains to be determined if these gene variants are associated with the muscle 
function of older individuals. 
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CHAPTER 4 . 
The Association of ACE I/Dand ACTN3 R577X Polymorphisms 
with 
Hand Grip Strength and Muscularity in Older Caucasian men. 
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4.1 Introduction 
An individual's muscular strength reaches its peak around the age of 30 and is well 
maintained until 50 years old (Deschenes, 2004). Beyond the fifTh decade oflife, strength 
tends to decrease at a pace of -15% per decade (Larsson et al., 1979), Thus ageing is a 
strong environmental influence on muscle function. Age associated losses in muscle 
strength and power can have a profound effect on a person's ability to live independently 
and contributes to an increased risk of falls. The decline in functional capacity has 
detrimental effects not only rates of injury but also morbidity and mortality (Rantanen et 
al., 1999; Rantanen et al., 2000). 
Grip strength has been found to be a strong predictor of physical functioning, disability, 
morbidity and mortality (Giampaoli et al., 1999) hence it is a suitable phenotype for 
identifying genetic variants of importance in mid and late life. In young men, the genetic 
contribution to strength measures appears to be 30-80%, depending on the angle, type 
and velocity of contraction (Thomis et al., 1998). Estimates of the grip strength 
heritability of older twins range from 30-65% (Arden and Spector, 1997; Frederiksen and 
Christensen, 2003; Cannelli and Reed, 2000; Frederiksen et al., 2003a). As genetic 
factors appear to account for a substantial proportion of the phenotypic variability of 
muscle function, further research is required to find the specific genetic variants that are 
responsible for this inheritance. 
The angiotensin converting enzyme (ACE) VD and a actinin 3 (ACTN3) R577X 
polymorphisms have received attention for their potential association with human 
perfonnance phenotypes. Case controlled studies have found good evidence that the ACE 
DD genotype and ACTN3 RR genotype are over represented in elite sprint and power 
athletes than controls (Myerson et al., 1999; Woods et al., 2001; Nazarovet al., 2001; 
Niemi and Majarnaa, 2005; Yang et al., 2003; Druzhevskaya et al., 2008; Papadimitriou 
et al., 2008), indicating that these genotypes may be associated with muscle function. 
ACE is recognised as a key enzyme in the renin-angiotensin system and the D allele 
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variant of the ACE gene is associated with higher concentrations of serum ACE activity 
(Rigat et al., 1990). ACE catalyses the production of ANG II, which appears to enhance 
skeletal muscle hypertrophy (Gordon et al., 2001; Westerkamp and Gordon, 2005), and 
degrades kinins (Brown et al. 1998), which have been shown to have growth inhibitory 
properties (Ishigai et al., 1997). a actinins are a family of actin-binding proteins found in 
humans (Blanchard et al., 1989). ACTN2 and ACTN3 are myofibrillar proteins located at 
the Z disk and stabilise the thin filaments and contractile apparatus (Squire, 1992). 
ACTN3 expression is restricted to type II muscle fibres (Mills et al., 2001) and the 
absence of ACTN3 could inhibit the performance of these fibres. , 
The findings from cross-sectional association studies of these candidate genes are more 
equivocal than the case-control studies with elite athletic groups. Several investigations 
have found no association of ACE genotype with isometric strength in young (Folland et 
al., 2000; Thomis et al., 2004; Woods et al., 2001b; Chapter 3) and older adults 
(Frederikson et al., 2003b). Although the D allele has been associated with the muscle 
volume of healthy older men and women (Charbonneau et al., 2008) a key determinant of 
strength and power. Other functional studies have found the D allele to be associated with 
greater isometric strength in COPD patients (Hopkinson et al., 2004) and in healthy 
young men (Williarns et aI., 2005). Two studies reported an association between ACTN3 
R577X genotype and muscle phenotypes in women (lower elbow flexor (Clarkson et aI., 
2005) and knee extensor (Walsh et al., 2008) strength (for the XX genotype», but not in 
men. 
In the previous study (Chapter 3) there was no association of ACE IID or ACTN3 RIX 
polymorphisms with the muscle function of young men. However ageing and the typical 
decline in muscle function that occurs represents a potent environmental influence. It is 
possible that the two candidate genes under consideration are associated with the muscle 
function phenotypes of older men by the interaction of ageing muscle with the 
environment. The possible genetic association with muscle function in older age should 
be considered due to the importance of muscle function to healthy ageing. 
70 
Chapter 4 
The objectives of this study was to demonstrate: (i) the feasibility of recruiting a 
substantial cohort of healthy older Caucasian men with a reasonably homogenous age 
range and physical activity status (ii) examine the association of ACE IID and AC1N3 
RIX with grip strength and muscularity of this cohort. 
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4.2 Methodology 
4.2.1 Screening 
The Loughborough University ethical advisory committee approved the study. One 
hundred and twenty three UK Caucasian men, aged 60-70 years, volunteered to 
participate in this study and provided written informed consent. Participants had no 
history of strength training, moderate-low overall physical activity «4 sessions of 
exercise per week) and were free from locomotor or neuromuscular disease. 
4.2.2 Anthropometric assessment 
Participants' height was measured with a wall-mounted stadiometer (Holtain Ltd, 
Crymych, Wales) and body mass with a beam balance scale (Avery Ltd, Fairmont, MN) 
whilst participants wore shorts and aT-shirt. Skinfold thicknesses were measured at four 
sites (biceps, triceps, suprailiac and subscapular) using Harpenden skinfold calipers 
(British Indicators Ltd, Wolverhampton, UK). The measures were taken on the right side 
of the body and repeated 3 times, in order to calculate an average value. From the sum of 
four skinfolds body density was calculated using the formula of Dumin and Womersley 
(1974) and percentage body fat estimated using the Siri equation (Siri, 1956). Fat mass 
and fat-free mass (FFM) were derived from the percentage body fat and body mass 
values. FFM was used as an indicator of whole body muscularity. 
Right and left forearm circumferences were measured using an anthropometric tape 
(Harpenden, British Indicators Ltd, London, UK). Maximum circumference of the 
proximal forearm, perpendicular to the long axis of the segment, was recorded while 
participants stood in the anatomical position. Skinfold thickness was determined at two 
sites on the forearm, lateralis and volaris (Eston and Reilly, 2001), using skinfold calipers 
(Harpenden, British Indicators Ltd, London, UK). Measurements were taken at least 
twice, if readings were discrepant by more that 0.2 mm a third measurement was taken. 
Circumference and skinfold measurements were averaged and an estimate of forearm 
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muscle and bone cross sectional area (lean forearm CSA) was calculated (Eston and 
Reilly, 2001) as an index of forearm muscularity. 
4.2.3 Grip strength 
Isometric hand grip strength was assessed with a JAMAR dynamometer (Samrnons 
Preston Rolyan, Illinois, USA). Participants were familiarised with the dynamometer and 
test procedure and were required to stand with feet shoulder width apart with their elbow 
flexed at an angle of 90° (1.57 rad), with the shoulder adducted. Verbal encouragement 
was given during the assessment. Participants performed three maximal efforts that were 
sustained for 3 s with 30 s rest between each contraction. If grip strength increased after 
the third maximal voluntary contraction (MVC) then a fourth contraction was performed. 
The highest value for each hand was recorded and the average of both hands gave one 
representative value for grip strength. 
4.2.4 Blood collection and genotype determination 
The participants' thumb was sterilised and capillary puncture at the tip of the thumb was 
performed with a sterile Accu-Chek lancet device (SoftcJix, Roche Diagnostics, 
Hergeshelt von, Germany). Blood was stained directly onto filter paper ready for 
genomic deoxyribonucleic acid (DNA) isolation. The blood stained filter paper was then 
left to dry at room temperature. Genomic DNA was later obtained from bloodstained 
filter paper using Chelex extraction and genotypes for the polymorphisms of ACE lID 
and ACTN3 RlX were determined as described previously (Chapter 3). 
4.2.5 Statistical analysis 
A Chi squared test was used to confIrm that the observed genotype frequencies for ACE 
and ACTN3 were in Hardy-Weinberg Equilibrium. All data were confirmed as normally 
distributed using SPSS for windows 12.0 (SPSS, Chicago, IL). A one way analysis of 
variance (ANOVA) was used to test the differences in strength between ACE IID and 
ACTN3 RIX genotypes. Statistical analyses were performed using SPSS for windows 
14.0 (SPSS, Chicago, IL) and Microsoft Excel 2000 for windows (Microsoft, Redmond, 
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WA). Data are presented as mean and standard deviation of the mean (SD) with statistical 
significance defined as P values of < 0.05. 
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4.3 ResuIts 
4.3.1 Physical characteristics 
The recruitment of 123 men who fitted the inclusion criteria demonstrated the feasibility 
of studying this population. The participants physical characteristics were (mean ± SD): 
age, 64 ± 3 yr; body mass, 85.5 ± 13.2 kg; height, 1.75 ± 0.07 m; body mass index, 27.8 ± 
3.7 kg'm,2; fat free mass, 60.5 ± 7.4 kg; body fat percentage, 28.9 ± 4.6 %; forearm 
muscularity, 51 ± 7 cm2. The distribution of ACE (ll 31, ID 59, DD 33) and ACTN3 (RR 
48, RX 59, XX 16) genotypes were in Hardy-Weinberg equilibrium. Physical 
characteristics were independent of ACE and ACTN3 genotypes (Table 4.1 and 4.2). 
Isometric grip strength did not differ between ACE and ACTN 3 genotypes (Figure 4.1). 
Table 4.1 Physical characteristics and grip strength in relation to ACE genotype 
11 ID DD P 
(n = 31) (n = 59) (n = 33) 
Anthropometry: 
Height (m) 1.74 ± 0.06 1.75 ± 0.07 1.77±0.07 0.32 
Body mass (kg) 85.7 ± 15 85.3 ± 13.2 85.8 ± 11.3 0.98 
Fat free mass (kg) 60.4± 8.2 60±7.6 61.4 ± 6.3 0.68 
Body fat (%) 28.9 ± 4.4 29.2±4.6 28.4±4.9 0.71 
Lean forearm CSA (cm2) 51±7 50±6 53±9 0.40 
Isometric grip strength (kg) 45±6 45±6 44±6 0.73 
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Table 4.2 Physical characteristics and grip strength in relation to ACTN3 genotype 
RR RX :xx p 
(n = 48) (n = 59) (n = 16) 
Anthropometry: 
Height (m) 1.75 ± 0.06 1.76 ± 0.08 1.78 ± 0.06 0.25 
Body mass (kg) 85 ± 12.4 85± 14 88 ± 12.7 0.55 
Fat free mass (kg) 60.5 ± 6.9 60.3 ± 8 61 ± 7.1 0.96 
Body fat (%) 28.5 ± 4.1 28.7±4.9 31.0±4.4 0.14 
Lean forearm CSA (cm') 51±7 51±7 52 ± 11 0.75 
Isometric grip strength (kg) 45±5 44±6 45±8 0.88 
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Figure 4.1 The association of ACE and ACTN3 genotype with isometric grip strength. There were no 
significant differences in strength for ACE (P = 0.73) or ACTN3 (P = 0.88) genotypes. Data are mean and 
SD (n = 123). 
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4.4 Discussion 
The first aim of this study was to evaluate the feasibility of recruiting a substantial 
population of healthy older Caucasian men. With the inclusion of 123 suitable volunteers 
it was demonstrated that gene-phenotype association studies with this cohort were 
feasible with the available resources. The second aim of this study was to investigate the 
association of ACE lID and ACTN3 RIX polymorphisms with muscle strength and 
indicators of muscularity in an older Caucasian male population. The two candidate gene 
polymorphisms considered were not associated with isometric grip strength, lean forearm 
CSA or whole body FFM. 
We endeavored to avoid the potentially confounding effects of ethnic diversity and 
chronic physical training in order to highlight the association of genes with strength. 
Therefore we recruited UK Caucasian volunteers with moderate to low levels of physical 
activity, which likely explains the wide variation in body composition. 
A high proportion of elite sprint athletes have been reported to have a DD genotype 
compared with endurance athletes and controls (Myerson et al., 1999; Woods et al., 
2001; Nazarov et a!., 2001), indicating that this genotype may be associated with skeletal 
muscle function. The current study did not find an ACE genotype association with 
isometric grip strength. These findings are similar to previous investigations reporting no 
. ACE genotype influence with strength in older individuals (Hopkinson et a!., 2004; 
Frederikson et al., 2003a; Charbonneau et al., 2008; Giaccaglia et al., 2008) and young 
adults (Folland et al., 2000; Thomis et al., 2004; Pescatello et al., 2006, chapter 3). 
Williarns et al. (2005) is the only study to have reported a DD association with isometric 
strength, albeit in younger people. 
As muscle size is a key determinant of muscle strength (Folland and Williarns, 2007) the 
similar forearm muscularity of the three ACE genotypes is coherent with our finding of 
no ACE genotype association with strength. It is in contrast, however, with a recent 
report of an association of ACE genotype with the muscle volume of healthy older men 
and women (Charbonneau et al., 2008). Furthennore in this study there was no 
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association of ACE or ACTN3 genotypes with any measure of body composition, 
although assessment of body composition using the sum of 4 skinfolds methods may lack 
validity. The sum of four skinfolds is considered a level III doubly indirect method of 
estimating body fat percentage, and thus also FFM, compared to a DXA scan which is 
categorised as a level II method (Eston and Reilly, 2001). 
ACTN 3 genotype was also considered in the present investigation. It has been suggested 
that the sarcomeres within skeletal muscle fibres are inherently weaker when they lack 
ACTN3 and that this may be associated with the muscle function of free living humans 
(Chan et a!., 2008). The frequency of the RR genotype has been found to be higher 
amongst elite sprinters (Niemi and Majamaa 2005), strength (Roth et al., 2008) and 
power athletes (Druzhevskaya et al., 2008, Papadimitriou et al., 2008) compared to 
endurance runners or controls. However, we found no association between ACTN3 
genotype and muscle strength or muscularity. The lack of an association between ACTN3 
genotype and isometric strength is similar to a number of other studies in young (Vincent 
et al., 2007; chapter 3) and older men (Walsh et al., 2008) but two studies have found 
lower strength in XX genotype women (Clarkson et al., 2005, Walsh et al., 2008), 
perhaps indicating a sex-genotype interaction. Given that ACTN3 is only present in type 
IIX fibres that are distinguished by their high velocity of shortening and hence capacity 
for producing power, functional tests at high velocities might be more likely to show an 
effect of this polymorphism (Clarkson et al., 2005). 
This study demonstrated the feasibility of recruiting a substantial population of healthy 
older Caucasian men for gene-muscle function phenotype investigation. In the present 
study, ACE lID and ACTN3 RlX polymorphisms were not associated with muscular 
strength or muscularity. However, the muscle function and body composition measures 
included in this study were relatively simplistic measures taken on just one occasion, that 
were not as comprehensive or as thoroughly collected as those in first study (Chapter 3). 
Further studies investigating the association between these polymorphisms with more 
comprehensive measures of muscle function and body composition of older persons are 
required. Specifically, dynamic strength of the knee extensors. 
78 
Chapter 5 
CHAPTERS 
ACE lID and ACTN3 R577X Polymorphisms, 
and the Muscle Function and Body Composition of Older Caucasian 
Men 
79 
Chapter 5 
5.1 Introduction 
A reduction in physical function due to lower strength and power in old age can have a 
profound effect on a person's ability to live independently, as carrying out daily tasks 
such as rising from a chair, or climbing stairs become increasingly difficult. Poor 
physical function in old age leads to an increased risk of older adults developing 
disabilities (Roubenoff, 2000). Beyond the fifth decade of life strength tends to decrease 
at -15% per decade (Larsson, 1979). A primary mechanism for the decrease in strength is 
sarcopenia - a progressive loss of muscle mass. Muscle power output and the ability to 
produce force quickly appears to decline more rapidly than strength (Metter et al., 1997; 
Skelton et al., 1994), which could be due to a preferential atrophy of type II muscle fibres 
(Lexell1995). The evoked contractile (twitch) response of the quadriceps has been found 
-10% slower in older compared to younger persons (Roos et al., 1992) and this may 
reflect a slowing of the contractile properties that contributes to the decline in power. 
Reductions in strength with age occur in both the upper limb and in the weight-bearing 
lower limb muscles (Izquirdo et al., 1999), the latter are important for locomotion, 
posture and prevention of falls, and consequently quality of life and morbidity. The 
overall rate of loss of strength in the quadriceps and hamstrings has been reported to be 2 
and 2.4% per year (Frontera et al., 2000). Strength of the quadriceps is a predictor of 
dependency and survival (Rantanen et al., 1999) therefore understanding the basis of 
dysfunction of this muscle group in old age has important clinical and social implications 
(Frontera et al., 2000). The decline in upper body strength with age (hand grip strength 
decreases by -3 % per year (Frontera et al., 2000)) compromises the ability for manual 
tasks. 
In young men, the genetic contribution to strength and power appears to be 30-80%, 
depending on the nature of the functional test employed (Thomis et al., 1998; Calvo et 
al., 2002). The heritability of lower extremity function (strength, power and walking 
speed) in older twins (>60 years) has been found to be 34-52% (Carmelli et al., 2000; 
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Tiainen et al., 2007). Finding the specific genetic variants responsible for this heritability 
in muscle function with ageing will enhance our understanding of the mechanisms 
regulating muscle weakness. Angiotensin converting enzyme (ACE) lID and Cl actinin 3 
RSS7X (ACTN3) polymorphisms have been suggested to have an association with the 
variations in skeletal muscle function. 
A high proportion of the ACE DD genotype has been reported in elite sprint athletes 
compared with endurance athletes and controls (Myerson et al., 1999; Woods et al., 
200 I; Nazarov et aI., 200 I), indicating that this genotype may be associated with skeletal 
muscle function. The D allele variant of the ACE gene is associated with higher 
concentrations of serum ACE activity (Rigat et aI., 1990). ACE catalyses the production 
of ANG n, which appears to enhance skeletal muscle hypertrophy (Gordon et al., 2001; 
Westercamp and Gordon 2005) and degrades kinins (Brown et al., 1998), which have 
growth inhibitory properties (Ishigai et al., 1997). There is recent evidence that ACE 
genotype is associated with the muscle volume of healthy older men and women 
(Charbonneau et al., 2008) a key determinant of muscle strength and power. The 
possibility that the DD genotype maybe associated with a greater proportion of fast 
twitch fibres (Zhang et al., 2003) could explain any association of the ACE D allele with 
strength/power, particularly at high velocities, but this evidence remains equivocal 
(Akhrnetov et al., 2006). Several investigations have found no association of ACE 
genotype with isometric and dynamic strength in young and older adults (Folland et al., 
2000; Thornis et al., 2004; Pescatello et al., 2006; Woods et al., 200Ib). However the D 
allele has been associated with greater isometric strength in COPD patients (Hopkinson et 
al., 2004) and isometric and isokinetic strength in healthy young men (Williams et al., 
2005). To date no studies have examined the association of ACE genotype with high 
velocity muscle strength and the contractile properties of older males. 
The Cl actinin 3 (ACTN3) RJX polymorphism (Mills et al., 2001) has also been identified 
as potentially associated with skeletal muscle composition, function and performance. 
ACTN3 expression is restricted to type IIX muscle fibres (Mills et al., 2001) and the 
absence of ACTN3 could inhibit the performance of these fibres that are important for 
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rapid powerful contractions (MacArthur and North, 2004). Moreover, there is also recent 
evidence that ACTN3 genotype may be associated with fibre type composition (Vincent 
et a/., 2007). The frequency of the RR genotype has been found to be higher amongst 
elite sprinters (Niemi et al., 2005; Yang et al., 2003), strength (Roth et al., 2008) and 
power athletes (Druzhevskaya et al., 2008; Papadimitriou et al., 2008) compared to 
endurance runners or controls, indicating a beneficial effect on skeletal muscle function 
and in particular the ability to generate powerful contractions at high velocity. The 
findings from cross-sectional association studies are more equivocal, however. We 
previously found ACTN3 genotype was not associated with the relative or absolute 
strength at high velocities, or the evoked contractile response, of young men (Chapter 3), 
but greater relative high velocity strength has been reported in young male R allele 
carriers (Vincent et al., 2007). The mechanistic actions of ACTN3 deficiency are 
currently being explored, with muscle from ACTN3 knockout (KO) mice found to have a 
slower contractile response and lower force generating capacity than those with ACTN3 
(Chan et al., 2008). Furthermore, KO mice have a reduced fast fibre diameter, lean mass 
and total body mass (MacArthur et al., 2008), which suggests a clear association of 
ACTN3 genotype with skeletal muscle growth and muscularity. ACTN3 has also been 
proposed as a candidate metabolic ally 'thrifty gene' (Neel, 1962) with the absence of 
ACTN3 hypothesised to improve energetic efficiency (MacArthur et al., 2004) that could 
promote energy storage and body fat accumulation. Whilst there has been little support 
for this in young people (Vincent et al., 2007; chapter 3) it is possible that an association 
may accrue over the lifespan. 
Many previous reports have studied populations with a mixed ethnic origin (Pescatello et 
al., 2006), wide age range (Clarkson et al., 2005; Walsh et al., 2008) or variable physical 
activity status (Woods et al., 2001; Hopkinson et al.; 2004), which could confound and 
potentially explain some of the contrasting findings for both ACE and ACTN3 
polymorphisms. For example skeletal muscle phenotypes are known to be influenced by 
ethnic origin (Newman et al., 2003). Furthermore, the measurement of different muscle 
groups, e.g. upper vs lower body, which may be exposed to different levels of habitual 
loading and therefore more or less reflective of genetic factors could also account for the 
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equivocal findings. The vast majority of the previous studies have examined the 
association of only single gene polymorphisms with muscle function. Considering that 
the association of a single gene variant is probably quite small (Williams and Folland, 
2008) any association of candidate genes should be investigated together in order to 
detennine broader genetic effects on a given phenotype. Therefore studies of multiple 
candidate genes are required. 
The aim of this study was to investigate the association of both ACE I/O and ACTN3 
RlX polymorphisms with the body composition and muscle function of 60-70 year old 
Caucasian men with a low-moderate level of physical activity. Measurements included 
isometric strength of a range of upper and lower body muscle groups and assessment of 
non-skeletal lean mass and fat mass by Dual-energy X-ray Absorptiometry (DXA). In 
addition the evoked twitch response and isokinetic strength at a range of velocities were 
used to detennine the contractile properties and dynamic strength of the knee extensors. 
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5.2 Methodology 
5.2.1 Protocol overview 
Participants visited the laboratory on three occasions. The first visit involved a range of 
muscle function measurements: hand grip, knee extensor and elbow flexor isometric 
strength of both limbs; the contractile properties of both knee extensors; and, isokinetic 
strength of the non dominant knee extensors at three velocities. On the second visit these 
functional measurements were repeated and a DXA scan assessed non-skeletal lean mass 
and fat mass. The third visit involved a fasted blood sample between 7.30 and 9.30 am. 
All functional measurements were performed between 9 am and 1 pm and repeated 
measurements were performed 1 week apart. 
5.2.2 Participants 
One hundred UK Caucasian males, aged 60-70 years, volunteered to participate in the 
study and provided written informed consent. Participants had no history of strength 
training, moderate-low overall physical activity «4 sessions of activity per week), were 
free from locomotor or neuromuscular disease and conditions known to influence muscle 
function. Ethical approval for this study was provided by the Loughborough University 
ethical advisory committee. All tests were conducted in conformity with the principles of 
the declaration of Helsinki. Participants' height was measured with a wall-mounted 
stadiometer (HoJtain Ltd, Crymych, Wales) and body mass with a beam balance scale 
(Avery Ltd, Fairmont, MN) whilst participants wore shorts and a T-shirt. 
5.2.3 Hand grip strength 
Isometric hand grip strength was assessed with a JAMAR dynamometer (Sarnmons 
Preston Rolyan, ILL). Participants were familiarised with the dynamo meter and test 
procedure and 'were required to stand with feet shoulder width apart with their arm flexed 
at an elbow joint angle of 90°, with the shoulder abducted. Verbal encouragement was 
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given during the assessment. Participants performed three maximal voluntary 
contractions (MVCs) that were sustained for 3 seconds and with 30 seconds rest between 
each contraction. If the third MVC was the highest then a fourth contraction was 
performed. The coefficient of variation (CV) for isometric grip strength over repeated test 
occasions was 3.7%. 
5.2.4 Elbow flexor and knee extensor isometric strength, and the contractile properties 
of the knee extensors 
Elbow flexor isometric strength as well as voluntary and electrically evoked isometric 
contractions of the knee extensors were assessed using a conventional isometric strength 
testing chair (Parker et al., 1990). Participants were seated in an upright position with the 
back supported and firmly secured with straps fastened at the hips and shoulders. Force 
was measured with a calibrated V-shaped aluminium strain gauge (Iones and Parker, 
• J 
1989). The strain gauge signal was sampled at 2,000 Hz with an analogue to digital (ND) 
converter (Micro 140 I, Cambridge Electronic Design Ltd, Cambridge, UK) and logged 
and displayed by PC with Spike 2 software (Cambridge Electric Design Ltd, Cambridge, 
UK). 
Participants performed a 5 min warm-up on a cycle ergometer (Monark 818e, Stockholm, 
Sweden) at -50 W. For knee extensor measurements, knee and hip joint angles were 90° 
(1.57 rad) and 110° (1.41 rad), respectively (0 represents full extension). Their lower leg, 
-2 cm above the ankle, was tightly strapped to a calibrated V-shaped aluminium strain 
gauge (Jones and Parker, 1989), that was always in the direct line of action of the applied 
force. Following some progressive sub-maximal contractions maximum isometric 
strength was determined by having participants perform 3-4 MVCs of the knee extensors, 
each of -3 s duration and with 30 s rest in-between. The between sessions CV for knee 
extensor isometric strength was 2.6%. 
Peak isometric elbow flexor strength was determined at a 90° (1.57 rad) elbow joint angle 
with the shoulder horizontally adducted, and the elbow resting on a rigid platform. A 
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wrist cuff was worn by participants with the strain gauge strapped to the participants' 
wrist. Following a series of sub-maximal contractions participants were instructed to 
perform three MVCs of the elbow flexors, each of -3 s duration with 20 s between 
attempts. The isometric strength of each arm and leg was recorded as the single highest 
value from the three attempts. The between sessions CV for elbow flexor isometric 
strength was 3.9%. 
The contractile properties of the knee extensors were measured using electrically 
stimulated contractions. The participants remained seated in the chair and 2 large (13 x 
10 cm) flexible carbon rubber electrodes (Electro Medical Supplies Ltd, Wantage, UK), 
coated with electrode gel (Camcare Gels, Ely, UK) were placed over the anterior surface 
of the quadriceps. Percutaneous electrical stimulation with unidirectional square wave 
pulses of 50 IlS duration was applied through a constant current Digitimer stimulator (DS 
7AH, Welwyn, Garden City, UK). The stimulation current began at 5 mA and gradually 
increased until the twitch response reached a plateau of maximal twitch force. The twitch 
response was filtered by applying a digital filter with a low pass frequency of 30 Hz and a 
transition gap of 16 Hz. Semi automated cursors within the spike 2 software were used to 
identify discrete events within each twitch. Time to peak tension (TPT) was taken as the 
time between force onset and peak twitch force, with force onset defined as 3% of peak 
gradient. Half relaxation time (HRT) was the time for the muscle to relax from peak 
twitch force to half peak force. The peak rate of force development (Peak RFD) during 
the twitch was assessed as the maximum gradient of the force-time graph. Three twitches 
were analysed, the average values were recorded for each leg. The CV for TPT, HRT and 
RFD over repeated test occasions was 3.6, 4.7 and 9.7 % respectively. 
5.2.5 Torque-velocity relationship o/the knee extensors 
Knee extensor torque of the non dominant leg was assessed at 3 velocities (0, 30 and 
2400 ·s· l ). Participants were seated in a Cybex Norm Isokinetic Dynamometer (Lumex 
Inc, NY, USA) with the axis of the knee joint aligned with the centre of rotation of the 
dynamometer arm, and the lower leg strapped to the lever arm just proximal to the ankle. 
Participants were restrained at the waist, shoulders and the distal part of the thigh, and the 
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backrest was set at 100° (1.73 rad) from the base of the seat. Peak torque of the knee 
extensors was assessed isometrically at 73° (1.27 rad) of knee flexion (identified by pilot 
work as the angle of peak torque) and isokinetically at 30 and 2400 ·s·1 (0.52,4.19 rad·s· I). 
The relative torque at high velocity (ratio of strength at 2400 ·s·1 to 300 ·s·l ) was calculated 
as a percentage. For isometric measurements there were 2 practice contractions at 50% 
effort followed by 3 MVCs. For the isokinetic measurements participants performed a set 
of practice trials of sub-maximal knee extension at each angular velocity, prior to 2 sets 
of 2 maximum contractions at 300 ·s·1 and 2 sets of 3 maximum contractions at 2400 ·s·l • 
There was at least 30 s rest between each set of contractions, and -60 s between 
velocities. The range of motion for the isokinetic measurements was from 120° - 15° 
(2.09 - 0.26 rad) of knee flexion. Knee extensor torque values were corrected for 
gravitational torque, and contractions at the highest velocity 2400 ·s·1 (4.19 rad·s· I» were 
typically isovelocity for at least the range 90° - 30° (1.57-0.52 rad). The CV for the 
torque measurements at 0,30 and 2400 ·s·1 over repeated test occasions was 5.7, 7.8 and 
8.3% respectively. 
5.2.6 Dual-energy X-ray Absorptiometry (DXA) 
On the 2nd visit a narrow angle fan beam DXA scan (Lunar Prodigy Advance DXA 
machine, GE Lunar, Madison, WI.) was performed whilst participants lay quietly on a 
couch fully clothed. The purpose of the whole body scan was to assess body composition, 
specifically non-skeletal lean mass, and fat mass. The non-skeletal lean mass component 
of body composition was the criterion measure of whole body muscularity. The scanner 
was calibrated daily, and an aluminium spine phantom was also scanned in order to 
confirm that there was no discernable drift during the course of the study. 
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5.2.7 Blood collection and genotyping 
A trained phlebotomist performed venous puncture. Participants lay in a semi-supine 
position whilst a 10 ml blood sample was obtained from a superficial forearm vein 
following a 12 hour fast to avoid lipemic sera. Blood samples were collected in a serum 
tube and applied onto filter paper in preparation for genomic deoxyribonucleic acid 
(DNA) isolation. All blood samples were left at room temperature for 1-2 hours to allow 
blood to clot. The samples were then spun at 2300 revs·min·1 (rpm) for 10 minutes at 4°C 
in a refrigerated centrifuge (Beckman Instruments, Palo Alto, CA) and stored at -20°C 
enabling the detennination of serum ACE activity on a separate occasion. Genomic DNA 
was obtained from previously bloodstained filter paper using Chelex extraction and 
genotypes for the polymorphisms of ACE lID. and ACTN3 RIX were determined as 
described previously (Chapter 3). 
5.2.8 Serum ACE activity 
Diagnostic determination of ACE activity in serum was carried out by an enzymatic 
assay using an automated spectrophotometer (Cobas Mira Plus, Roche, Switzerland). The 
enzyme mediates the cleavage of a synthetic substrate and the kinetics of this cleavage 
reaction are measured following the decrease in absorbance at 34Onm. This was 
measured twice with the Biih1mann ACE kinetic kit (Biihlmann Laboratories AG, 
Schonenbuch, Switzerland). The intra-assay CV for the serum ACE measurements was 
4%. 
5.2.9 Statistical analysis 
A Chi squared test was used to confirm that the observed frequencies for ACE and 
ACTN3 genotypes were in Hardy-Weinberg Equilibrium. Data was confirmed as not 
normally distributed using SPSS for windows 12.0 (SPSS, Chicago, IL). A Kruskal-
Wallis test (a non parametric version of ANOVA) was used to assess the differences in 
strength, contractile properties, body composition and serum ACE activity between ACE 
lID and ACTN3 RIX genotypes. A Pearson's product moment correlation was used to 
examine the relationship between serum ACE activity and the other variables. Statistical 
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analyses were perfonned using SPSS v12.0 (SPSS, Chicago, IL) and Microsoft Excel 
2000 (Microsoft, Redrnond, WA). Data are presented as mean and standard deviation 
(SD) with statistical significance defined as P < 0.05. 
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5.3 Results 
5.3.1 Physical characteristics 
The participants physical characteristics were (mean ± SD): age, 65 ± 3 yr; body mass, 
83.5 ± 11.4 kg; height, 1.76 ± 0.06 m; body mass index, 26.9 ± 3.3 kg·m-2; non-skeletal 
lean mass, 56.9 ± 5.5 kg; fat mass 22.9 ± 7.1 kg. The distribution of ACE (ll 25, ID 48, 
DD 27) and AC1N3 (RR 43, RX 41, XX 16) genotypes were in Hardy-Weinberg 
equilibrium. Physical characteristics were independent of ACE and AC1N3 genotypes. 
5.3.2 ACE liD polymorphism and serum ACE activity in relation to muscle 
phenotypes: strength, contractile properties and muscularity 
ACE genotypes had similar non-skeletal lean mass (P = 0.41; Table 5.1) and fat mass (P 
= 0.22; Table 5.1). No differences existed between ACE genotypes for knee extensor 
isokinetic torque at any velocity from 0-2400 ·s-1 (0.27 < P < 0.67; Figure 5.1A) or the 
relative torque at high velocity (P = 0.60; Table 5.1). The evoked twitch response was 
similar for the three ACE genotypes (TPT, P = 0.79; HRT, P = 0.73; Peak RFD, P = 
0.43; Table 5.1). Isometric strength of the knee extensor (P = 0.55; Table 1), elbow flexor 
(P = 0.60; Table 5.1) and handgrip (P = 0.38; Table 5.1) muscles were independent of 
ACE genotype. Serum ACE activity for the whole group was 46.7 ± 20.2 UIL and this 
was influenced by ACE genotype (ll 34.5 ± 14.6; ID 44.4 ± 17.7; DD 61.8 ± 20.4 U/L; P 
< 0.001). 
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Table 5.1 Physical characteristics and muscle function of the different ACE genotypes. Data are mean:t 
SD 
11 ID DD P 
(n = 25) (n = 48) (n =27) 
Anthropometry: 
Height (m) 1.74±0.05 1.76 ± 0.06 1.77 ± 0.05 0.16 
Body mass (kg) 80.9 ± 9.3 86.2 ± 12.2 81.3 ± 10.8 0.12 
Lean mass* (kg) 55.7±4.7 57.5±5.2 56 ± 5.5 0.41 
Fat mass (kg) 22.3 ± 5.8 24.3±8.1 20.9±5.9 0.22 
Isometric Strength: 
Knee extensors (N) 474±76 498±84 487±73 0.55 
Elbow Flexors (N) 266±34 272±33 266 ± 31 0.60 
Handgrip (kg) 44±5 44±5 43±6 0.38 
Relative Isokinetic Torque 
240:300 ·s·1 (%) 55±6 52±7 53±6 0.15 
Contractile Properties: 
TPT(s) 71 ±06 73±09 71 ±07 0.65 
HRT (s) 94±09 93 ± 13 95 ± 16 0.93 
Peak RFD (N·S·I) 2075 ± 644 2150 ± 604 2011 ± 507 0.43 
• Non·skeletallean mass 
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Serum ACE activity was negatively correlated with the relative torque at high velocity (R 
= - 0.23, P = 0.03). There was a tendency for serum ACE activity to be correlated with 
quadriceps (R = 0.19; P = 0.07) and elbow flexor (R = 0.20; P = 0.06) isometric strength. 
Serum ACE activity was not correlated with any other functional, contractile or body 
composition measurement (0.13<P<0.86). 
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Figure 5.1 Relationship between serum ACE activity and relative torque at high velocities (r = - 0.23, P = 
0.03, n=\OO). 
5.3.3 ACTN3 R577X polymorphism in relation to muscle phenotypes: strength, 
contractile properties and muscularity 
No differences existed between ACTN3 genotypes for non-skeletal lean mass (P = 0.72; 
Table 5.2). There was a significant difference in fat mass between genotypes (P = 0.04; 
Table 5.2; Mann Whitney corrected P = 0.045) with XX genotype individuals having 
higher fat mass than RR individuals. There was a tendency for differences in body mass 
(P = 0.09; Table 5.2) between ACTN3 genotypes. ACTN3 genotypes had similar knee 
extensor isokinetic torque at each velocity from 0-240°·s·! (0.53 < P < 0.99; Figure 5.IB) 
and relative torque at high velocity (P = 0.44; Table 5.2). No significant differences 
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existed between ACTN3 genotypes for the evoked twitch response (TPT, P = 0.89; HRT, 
P = 0.19; Peak RFD P = 0.39; Table 5.2). Knee extensor isometric strength (P = 0.77; 
Table 5.2) elbow flexor strength (P = 0.68; Table 5.2) and handgrip strength (P = 0.75; 
Table 5.2) were independent of ACTN3 genotype. 
Table 5.2 Physical characteristics and muscle function of the different ACTN3 genotypes. Data are mean i: 
SD 
RR RX XX P 
(n = 43) (n = 41) (n = 16) 
Anthropometry: 
Height (m) 1.75 ± .06 1.76 ± .06 1.79 ± .04 0.14 
Body mass (kg) 80.8 ±9.7 84.9± 12.6 87.3 ± 11.2 0.09 
Lean mass* (kg) 56 ±3.6 57.3 ± 6.3 58.3 ± 7.3 0.72 
Fat mass (kg) 20.9±5.9 23.7 ± 7.8 25.9±6.7 0.04 
Isometric Strength: 
Knee extensors (N) 483 ±66 495 ± 86 477±49 0.77 
Elbow Flexors (N) 269 ±32 270±36 266±26 0.68 
Handgrip (kg) 43±4 44±6 45±7 0.75 
Relative Isokinetic Torque: 
240:300 ·s·1 (%) 53 ±6 52±6 53 ±6 0.65 
Contractile Properties: 
TPT (ms) 72±08 72±09 72±08 0.95 
HRT(ms) 93 ± 14 97± 13 92± 15 0.26 
Peak RFD (N·S·I) 2026 ± 555 2102 ± 641 2281 ± 499 0.39 
• Non·skeletallean mass 
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Figure 5.2 The association of ACE (A) and ACTN3 (B) genotypes with the knee extensor torque·velocity 
relationship. There were no significant differences in torque at any velocity for either genotype 
(0.27<P<O.67, n=IOO) 
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5.4 Discussion 
The aim of this study was to evaluate the association of ACE IID and ACTN3 RJX 
polymorphisrns with phenotypes of muscle function and body composition in an ageing 
male population. Specifically it examined the association ofthese candidate gene variants 
with a range of muscle strength measurements, non-skeletal lean mass, fat mass, as well 
as the evoked contractile response (twitch) of the quadriceps. ,The ACE IID and ACTN3 
RJX polymorphisrns were not associated with muscle strength at any velocity, the twitch 
response of the quadriceps or non-skeletal lean mass of an ageing male population. There 
, 
was, however, an association of ACTN3 genotype with fat mass (greater fat mass of XX 
vs RR) in this cohort of older Caucasian men. 
Every effort was made to ensure that the participants made genuinely maximal 
contractions and the reliability of measurements was high (CV: 2.6 - 8.3 %). We 
endeavoreu to avoid the potentially confounding effects of chronic physical training, age, 
gender or ethnic diversity in order to highlight the association of these two candidate 
genes. Therefore older OK Caucasian men with moderate to low levels of physical 
activity were recruited. 
The lack of an ACE genotype association with isometric muscle strength, for a range of 
upper and lower body muscle groups, in this older population is similar to previous 
findings in older (Hopkinson et al., 2004; Frederikson et al., 2003) and young healthy 
adults (Folland et al., 2000; Thomis et aI., 2004; Pescatello et al., 2006). To date, only 
one study has reported a greater isometric strength of young adults with the DD genotype 
(Williams et al., 2005). As muscle size is a key determinant of muscle strength (Foil and 
and Williams, 2007) the similar non-skeletal lean mass, our criterion measure of 
muscularity, of the three ACE genotypes is' coherent with our finding of no ACE 
genotype association with strength. Although another recent report found ACE genotype 
is associated with the muscle volume of healthy older men and women (Charbonneau et 
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al., 2008), our data suggests at most a very small association of ACE genotype with 
muscle mass and isometric strength with ageing. 
Dynamic strength and power are critical aspects of muscle function, particularly in older 
age, that have greater validity for general mobility and locomotion than isometric 
strength and as such identifying genetic variations that are associated with dynamic 
strength and power are important. This study was the first to examine the asociation of 
ACE genotype with the torque-velocity relationship, particularly high velocity torque, 
and the time course of a twitch response, in an older population. We found no evidence 
that ACE genotype is associated with muscle phenotypes of dynamic strength and power 
or rapid contractile propertie~ in 60-70 year old men. There are conflicting reports for the 
association of ACE genotype with skeletal muscle fibre type composition (Zhang et al., 
2003; Akhmetov et al., 2006). Both relative torque at high velocity, the 240:30··s·1 ratio, 
and the time course of the twitch response are thought to reflect fibre type composition 
(Gur et al., 2003; Edwards et al., 1997), but the similarity of our results for these 
functional indicators suggests no strong ACE genotype association with the fibre type 
composition of older Caucasian men. Our previous work also found no association of 
ACE genotype with these same measures of muscle function in young men (Chapter 3), 
although one previous study did find greater knee extensor torque in young DD genotype 
males at 1.05 rad·s·1 (Williams et al., 2005). 
It is of note that the majority of association studies which have found no ACE genotype 
association with muscle strength are in contrast with the case-control studies, that have 
reported the D allele to be overrepresented in elite athletic events requiring muscle power 
(Jones and Montgomery, 2002; Woods et al., 2001a). It may be that the association of 
ACE genotype with muscle function is only apparent in the extreme phenotypes such as 
that of elite athletes and might indicate an interaction with powerful long-term 
environmental factors e.g. physical activity. If this were the case then extreme 
phenotypes of muscle weakness may also demonstrate an association with ACE 
genotype. Elderly individuals who are prone to falling are known to have a muscle 
function phenotype of unusually low strength and power (Perry et al., 2007; Pijnappels et 
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aI., 2008) and may also show an ACE genotype distribution that is different to that of 
controls. 
In keeping with the established literature ACE genotype was associated with serum ACE 
activity (Rigat et al., 1990). In contrast to ACE genotype, serum ACE activity was related 
to some functional phenotypes. Serum ACE activity was negatively correlated with the 
relative torque at high velocity i.e. as ACE activity increased the relative torque at high 
velocity decreased. Serum ACE catalyses the production of ANG U, which has been 
found to promote the preferential hypertrophy of slow twitch fibres (Gordon et al., 2001), 
and this could explain a steeper decline in strength as velocity increases. The positive 
relationships between serum ACE activity with quadriceps isometric and elbow flexor 
strength also approached significance, and indicates a weak association of serum ACE 
activity (coefficients of determination 4 %) with these aspects of muscle function. These 
tendencies for a relationship between serum ACE and isometric strength are in contrast to 
our findings of no association in young males (Chapter 3), but similar to the findings of 
Williams et al. (2005) who also found serum ACE to correlate with the isometric and 
isokinetic knee extensor strength of young men. The contrasting findings for ACE 
genotype and serum ACE may be due to the latter being a continuous variable, which is 
more powerful for seeking an association than a categorical variable. This supports the 
use of ACE activity measures as well as genotype in the conduct of future studies. 
However the use of multiple testing such as that of serum ACE activity with the number 
variables measured may increase the likelihood of a type I error. 
ACTN3 genotype was not associated with absolute or relative torque at high velocity, the 
time course of the twitch response or in fact any measure of muscle function. These 
findings are in agreement with previous studies of absolute dynamic strength in young 
men (Chapter 3, Walsh et al., 2008) and older men and women (Delmonico et al., 2008). 
Taken together these studies are contrary to the proposed role of ACTN3 in fast twitch 
fibres and its suggested advantageous effect on skeletal muscle function, particularly the 
ability to generate powerful contractions at high velocity (Yang et al., 2003). In contrast, 
Vincent et al. (2007) reported greater relative high velocity torque and type IIX fibre 
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composition of RR compared to XX genotype men. In support of this possibility, 
MacArthur et al. (2008) found that muscle from ACTN3 knockout mice displayed a 
slower contractile response suggesting that ACTN3 deficiency results in fast twitch fibres 
developing more oxidative properties that slower twitch fibres possess (Chan et al., 
2008). However, in older free living men we found no evidence of an ACTN3 association 
with the contractile properties, or absolute or relative dynamic strength of the knee 
extensors. It is increasingly recognised that individual genes are likely to have only a 
small association with physical function (Williarns and Folland, 2008) and this may help 
to explain the conflicting reports from single gene association studies. 
The lack of an association between ACTN3 genotype and isometric strength is similar to 
a number of other studies in young (Vincent et al., 2007; chapter 3) and older men 
(Walsh et al., 2008) but two studies have found lower strength in XX genotype women 
(Clarkson et al., 2005; Walsh et al., 2008), perhaps indicating a sex-genotype interaction. 
ACTN3 has been proposed as a candidate metabolically 'thrifty' genotype (Neel, 1962). 
In this cohort of older men XX genotype individuals displayed higher fat mass compared 
to RR genotype individuals, and there was a tendency for higher body mass in XX 
individuals. Thus our data supports the hypothesis that ACTN3 is associated with the 
body composition and adiposity of older men. The absence of ACTN3 from muscle fibres 
has been hypothesised to promote a more efficient use of energy. MacArthur et al. (2008) 
found greater activity of a range of mitochondrial aerobic enzymes, including 
components of the citric acid cycle, electron transport chain and l3-oxidation, in ACTN3 
KO mice, that overall represented a clear shift towards the metabolic properties of type I 
fibres. As type I fibres are known to be more efficient than type II fibres (Coyle et al., 
1992; Mogensen et al., 2006), such a metabolic shift would be expected to reduce energy 
use and increase energy storage and provides a likely explanation for the greater 
adiposity of older XX genotype men. Studies of young people employing arguably less 
sensitive methods of body composition assessment (skinfolds (Chapter 3) and 
bioelectrical impedance (Vincent et al., 2007) have not reported an ACTN3 genotype 
association with adiposity. However, a subtle genetic association with energy balance 
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may only become apparent over a prolonged period of several decades. A greater contrast 
to our findings is a recent study that employed DXA and found no ACTN3 association 
with the body composition of men aged 22-90 yr of unspecified ethnicity and physical 
activity status (Walsh et al., 2008). The wide age range, ethnicity and physical activity 
level of participants in their study may' have confounded their ability to detect the 
ACTN3 genotype association with fat mass that we have found. Therefore over more 
than six decades of the life span of healthy free living men ACTN3 genotype appears to 
be associated with energy balance and the accumulation of body fat. This difference in 
adiposity has clear implications for the cardiovascular and metabolic health of older 
Caucasian men. Given the widely documented influence of body fatness on overall 
health, morbidity and mortality (Zhang et al., 2008) this is an important finding that 
requires further research. 
To conclude, ACE lID and ACTN3 RIX polymorphisrns were not associated with whole 
body muscularity or muscle function phenotypes including isometric strength, strength at 
high velocities or the time course of the twitch response. Any association of these 
individual polymorphisms was not of sufficient magnitude to effect muscle function in an 
ageing male Caucasian population. Serum ACE activity may have a small association 
with the isometric and dynamic strength of older men. However, ACTN3 genotype was 
associated with increased fat mass in XX individuals, that suggests this polymorphism 
may be associated with the accumulation of body fat over the life span of older men. 
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CHAPTER 6 
The Distribution of ACE lID and ACTN3 R577X Genotypes 
Amongst Frequent Fallers and Healthy Controls. 
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6.1 Introduction 
Falls are a major health issue for the ageing population. It is estimated that 30-50% of 
people over the age of 65 years of age experience at least one fall per year (Campbell et 
a!., 1981), and about half of these will suffer recurrent falls (Masud and Morris, 2001). 
Falls frequently result in trauma, musculo-skeletal injury and disability. Approximately 
20% of falls require medical attention; 15% results in joint dislocations, soft tissue 
bruises, and concussions (Kannus et al., 1999). With ageing the skeleton becomes 
progressively weaker therefore, falling when bones are in a weakened state increases the 
likelihood of a fracture with 5% of falls resulting in fracture (Kannus et al., 1999). As 
well as a high financial burden and morbidity falls typically contribute to decreased 
quality of life (Robbins et al., 1989) and increased fear of falling, that leads to a reduction 
in activity and can cause a downward spiral of inactivity-related disability (Simey et al., 
1999). 
Numerous epidemiological studies have identified a multitude of risk factors for falling 
(Lord and Dayhew, 2001). Biological ageing results in an unavoidable decrease in 
maximal and explosive force production capacity (Skelton et al., 1994), specifically 
strength and power of the lower limb muscles which is the primary risk factor for falling 
(American Geriatrics Society, 2001). Beyond the fifth decade of life strength tends to 
decrease at -15% per decade (Larsson et al., 1979). A primary mechanism for the 
decrease in strength is sarcopenia - a progressive loss of muscle mass. Muscle power 
output and the ability to produce force quickly also declines with age and appears to 
decline more rapidly than strength (Metter et al., 1997; Skelton et al., 1994) which could 
be due to a preferential atrophy of type II muscle fibres (Lexell, 1995). Critically the 
reductions in strength with age are most pronounced in the weight-bearing lower limb 
muscles (Izquierdo et a!., 1999). The overall rate of loss of strength in the quadriceps and 
hamstrings has been reported to be 2 and 2.4% per year (Frontera et al., 2000). The 
continual decline in muscle strength and power restricts locomotion and contributes to a 
loss of mobility and increased risk of falls. Individuals who fall repeatedly (frequent 
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fallers) have lower muscle function (strength and power) than non-fallers (Perry et al., 
2007; Pijnappels et al., 2008). Perry et al. (2007) reported a faUs group had 85% of the 
strength and 79% of the power of non-fallers measured by isometric, concentric and 
eccentric strength of the knee and ankle muscles and leg extension power. Thus frequent 
fallers may represent an extreme phenotype of muscle weakness that is partially due to 
inherited genetic factors. 
Muscle function is influenced by inherited genetic factors as well as environmental 
variables (activity, nutrition etc). In young men, the genetic contribution to muscle 
strength and power appears to be 30-80%, depending on the nature of the functional test 
employed (Thomis et al., 1998; Calvo et aI., 2002). The heritability of lower limb 
function (strength power and walking speed) in older twins (>60 years) has been found to 
be 34-52% (Carmelli et al., 2000; Tiainen et al., 2007). ACE and ACTN3 genotypes have 
been suggested to account for the influence of inheritance upon muscular phenotypes of 
older adults (Charbonneau et al., 2008; Walsh et al., 2008). 
The possibilitY,that the DD genotype, of the ACE gene, maybe associated with a greater 
proportion of fast twitch fibres (Zhang et al., 2003) could explain any association of the 
ACE D allele with strength/power but this evidence remains equivocal (Akhmetov et al., 
2006). Case controlled studies have found good evidence that the ACE DD genotype and 
ACTN3 RR genotype are over represented in elite sprint and power athletes than controls 
(Myerson et al., 1999; Woods et aI., 2001; Nazarov et al., 2001; Niemi and Majarnaa, 
2005; Yang et al., 2003; Druzhevskaya et al., 2008; Papadimitriou et al., 2008), 
indicating that these genotypes may be associated with muscle function. 
The findings from cross-sectional association studies of these candidate genes are more 
equivocal, however, than the case-control studies with elite athletic groups. Several 
investigations have found no association of ACE genotype with isometric strength in 
young (Folland et al., 2000; Thomis et al., 2004; Woods et al., 2001; Chapter 3) and 
older adults (Frederikson et al., 2003b; Chapter 4, Chapter 5). Although the D allele has 
been associated with the muscle volume of healthy older men and women (Charbonneau 
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et al., 2008) a key detenninant of strength and power. Other functional studies have 
found the D allele to be associated with greater isometric strength in COPD patients 
(Hopkinson et al., 2004) and in healthy young men (Williams et al., 2005). Two studies 
reported an association between ACTN3 RIX genotype and muscle phenotypes in women 
(lower elbow flexor (Clarkson et al., 2005) and knee extensor (Walsh et al., 2008) 
strength (for the :xx genotype), but not in men. Additionally we previously found 
ACTN3 genotype was not associated with isometric strength in men (Chapter 3; Chapter 
4; Chapter 5). 
Due to the possible ACE and ACTN3 associations with muscle function it is plausible 
that these genotypes could be associated with susceptibility to falls. However, the 
association between these genes and the incidence of falls has not been examined. The 
aim of this study was to detennine if the frequency of ACE and ACTN3 genotypes was 
different in frequent fallers compared to a reference population. This work may help to 
clarify the role of these polymorphisms in falls risk. 
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6.2 Methodology 
6.2.1 Participants 
Seventy one UK Caucasian males (27) and females (44) (82 ± 7 years), volunteered to 
participate in this study and provided written informed consent. Participants were patients 
referred to the falls clinic and had at least 2 falls in the previous 12 months. Participants 
were excluded if they suffered from fainting or blackouts ( syncope), lacked mental 
alertness (scoring less than 70% on the Mini Mental State Examination MMSE), or had 
difficulty with communication and understanding. Participants were free from diseases of 
the muscles or nervous system (e.g. myositis, muscular dystrophy, myopathy, 
Parkinson's, stroke). The Derbyshire NHS Research Ethics Committee and 
Loughborough University ethical advisory committee provided ethical approval for this 
study. Control group genotype frequencies were obtained from the populations studied in 
Chapter 3 and Chapter 5. The falls group consisted of male and females, with their 
genotype frequencies compared to the control group of males only. 
6.2.2 Measurements 
Participants were questioned on falls history to ensure that they were frequent fallers. i.e. 
who had experienced a fall at least 2 times in the previous 12 months. Participants' height 
was measured with a portable stadiometer (Seca 214, UK) and body mass was recorded 
fully clothed with sit on scales (Seca 954, UK). Isometric hand grip strength was 
assessed with a JAMAR dynarnometer (Sammons Preston Rolyan, ILL). Participants 
were familiarised with the dynarnometer and test procedure and were required to sit with 
their arm flexed at an elbow joint angle of 90°, with the shoulder abducted. Verbal 
encouragement was given during the assessment. Participants performed three maximal 
voluntary contractions (MVCs) with each hand, and these were sustained for 3 s with 30 s 
rest between contractions. If the third MVC was the highest then a fourth contraction was 
performed. 
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6.2.3 Blood collection and genotyping 
A trained phlebotomist perfonned venous puncture. Participants sat upright whilst a 5 ml 
blood sample was obtained from a superficial foreann vein. Blood samples were 
collected in an EDTA monovette and frozen in preparation for genomic deoxyribonucleic 
acid (DNA) isolation. 
Genomic DNA was obtained from whole blood using the Nucleon kit (Nucleon BACC3 
kit, Arnersham Biosciences Ltd, UK) and genotypes for the polymorphisms of ACE IID 
and ACTN3 RIX were determined. ACE IID polymorphism was typed using polymerase 
chain reaction (PCR) based amplification. Extracted DNA was diluted to approximately 
50ng and used for PCR amplification. The final reaction mixture of 15 ilL for ACE 
contained: ACE Forward and Reverse Primers at 0.3 ilL each, 2 ilL of extracted DNA, 
7.5 ilL 2xReddy mix (ABgene) which contained 1.25 units Thennoprime Plus DNA 
Polymerase, 75 mM Tris-HCI, 20 mM(Nli!)2S04, 2.5 mM MgCh, O.ot % (v/v) Tween® 
20 and 0.2 mM each of dATP, dCTP, dGTP and dTTP and precipitant and red dye for 
electrophoresis and 4.9 ilL H20. The PCR reaction conditions protocol (Table 3.1) was 
programmed onto and run on a Mastercycler PCR machine (Eppendorf, Hamburg, 
Gennany). Mistyping of ID heterozygote has been found in some studies to occur due to 
preferential amplification of the D allele, and inefficiency in the amplification of the I 
allele. To ensure confidence in genotyping 8 samples were randomly chosen and retyped 
all of which give the same score. Additionally to increase the specificity of DD 
genotyping, PCR amplifications were also perfonned with an I-specific primer pair 
(5'TGGGACCACAGCGCGCCCGCCACTAC3 'and 
5'TCGCCAGCCCTCCCATGCCCATAA3') in all the samples that were found to be DD 
after amplification with the flanking primers. Briefly I-specific amplification was 
perfonned using 25 ilL reaction with 1 min denaturation at 94°C, followed by 30 cycles 
of 30s at 94°C, 45s at 67°C (annealing), and 2 min at 72 °c (extension). The 335bp 
fragment was identified on 2% agarose gel containing sybr safe (SYBR® Safe DNA gel 
stain, Invitrogen, Molecular Probes, USA). Under these conditions only the I allele 
produces a 335bp amplicon. The reaction yielded no products in a sample of all the DD 
genotypes. 
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ACTN 3 polymorphism was typed using PCR. The final reaction mixture of 20 ilL for 
ACTN 3 contained: ACTN3 Forward and Reverse Primers at 1 ilL each, 10 ilL of 2x 
Reddy Mix, (5 mM MgCb) (AB gene), 2 ilL of extracted DNA and 6 ilL H20. The PCR 
reaction conditions protocol (Table 3.1) was progrannned onto and run on Mastercycler 
PCR machine (Eppendorf, Hamburg, Germany) (Table 3.1). 
PCR product (15 ilL) for ACE was electrophoresed at 120 V for 45 minutes through a 
2% agarose gel containing -0.5 Ilglml sybr safe in TBA, ethylenediaminetetraacetic acid 
(EDTA) electrophoresis buffer pH 8.3 (TBE). A 100bp ladder (Abgene) was used to 
identify 190 and 490bp fragments for the ACE I/O polymorphism. A UV transilluminator 
(UVP, Cambridge, UK) was then used to visualize and score DNA fragments. 
Following genomic DNA amplification, ACTN3 PCR product was digested using DdeI 
restriction enzyme (New England, Biolabs Inc., Ipswich, MA) at 37°C for 4 h 
(Mastercycle, Eppendorf). The reaction mixture of20 III contained: 0.4 ilL Enzyme DdeI, 
2 ilL of 10x NEBuffer 4 (PH 7.9 at 25°C) constituting of 50 mM potassium acetate, 20 
mM Tris-acetate, 10 mM magnesium acetate and ImM dithothreitol, 0.2 ilL 100x bovine 
serum albumin (BSA), 7.6 III H20 and 10 III ACTN3 PCR product. The recognition site 
for the DdeI restriction enzyme was CTNAG (5'-3'). To ensure confidence in genotyping 
8 samples were randomly chosen and retyped all of which give the same score. 
PCR product (15 ilL) for ACTN3 was then electrophoresed at 120 V for 90 minutes 
through a 3% agarose gel containing -0.5 Ilglml syber safe (SYBR® Safe DNA gel stain, 
Invitrogen, Molecular Probes, USA), ethylenediaminetetraacetic acid (EDTA) 
electrophoresis buffer pH 8.3 (TBE). A 100bp ladder (Abgene) was used to identify 86, 
97, 108 and 205bp fragments distinctive of the ACTN3 polymorphism. A UV 
transilluminator (UVP, Cambridge, UK) was then used to visualize and score DNA 
fragments. 
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6.2.4 Statistical analysis 
A Chi squared test was used to confinn that the obselVed frequencies for ACE and 
ACTN3 genotypes were in Hardy-Weinberg Equilibrium. Statistical analyses were 
perfonned using SPSS v12.0 (SPSS, Chicago, IL) and Microsoft Excel 2000 (Microsoft, 
Redmond, WA). Data was confinned as nonnaIly distributed by the skewness and 
kurtosis using SPSS. A contingency chi-square was used to compare genotype frequency 
between population groups i.e. falls group vs. control group; male falls group vs. control 
group and female falls group vs. control group. ANOV A was used to assess the 
differences in strength and body mass between ACE lID and ACTN3 RIX genotypes. 
Data are presented as mean and standard deviation (SD) with statistical significance 
defined as P < 0.05. 
107 
Chapter 6 
6.3 Results 
The participants physical characteristics were (mean ± SD): age, 82 ± 7 yr; body mass, 
70.7 ± 17.3 kg; height, 1.61 ± 0.10 m; body mass index, 26.4 ± 7.5 kg·m-2• The 
distribution of ACE (Il 19, ID 33, DD 17) and ACTN3 (RR 25, RX 35, XX 11) 
genotypes were in Hardy-Weinberg equilibrium. The number of falls experienced by 
participants was 5 in the previous 12 months (range 2-20). 
No differences were observed between the falls group and control group for ACE (Table 
6.1) and ACTN3 (Table 6.1) genotype distribution (Table 6.2). 
Table 6.1 Falls group (ACE n=69, AC1N3 n=71) vs Control group (n=1 79) 
ACE ACTN3 
p p 
Falls group 
vs 0.53 0.77 0.76 0.68 
Control group 
Table 6.2 Percentage of ACE and AC1N3 genotypes in falls group vs control group 
ACE ACTN3 
11 ID DD RR RX XX 
Falls group n 19 33 17 25 35 11 
("10) (27.5) (47.8) (24.7) (35.1) (49.3) (15.5) 
Control group n 42 88 49 70 78 31 
(%) (23.4) (49.2) (27.4) (39.1) (43.6) (17.3) 
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Physical characteristics were independent of ACE and ACTN3 genotypes (Table 3). No 
differences were observed between ACE genotypes for isometric hand grip strength (P = 
0.45). No differences were observed between ACTN3 genotypes for isometric hand grip 
strength (P = 0.64) (Table 3). 
Table 6.3 ACE lID and AC1N3 R577X polymorphism in relation to physical characteristics and hand grip 
strength 
Falls group n = 69 ACE genotype 
11 (n = 19) ID (n = 33) DD(n=l7) P 
Height (m) 1.62 ± 0.09 1.61 ± 0.12 1.58 ± 0.08 0.51 
Body mass (kg) 68.2 ± 17.2 71.8 ± 18 73 ± 17.1 0.69 
BMI (kg·m-2) 24.4 ± 8.4 26.7 ± 7.3 29.4 ± 6.5 0.18 
Handgrip strength (kg) 12± 10 13±11 9±7 0.45 
Falls group n = 71 ACTN3 genotype 
RR(n = 25) RX (n = 35) XX(n = 11) p 
Height (m) 1.62 ± 0.12 1.62 ± 0.09 1.56 ± 0.09 0.22 
Body mass (kg) 69 ± 19.4 71.8 ± 15.5 69.7 ± 19.2 0.87 
BMI (kg·m-2) 25.2 ± 10.5 26.5 ±7.6 27.0±6.2 0.82 
Handgrip strength (kg) 13±1O 11 ±9 11 ± 10 0.64 
No differences were observed between genotype frequencies and distributions when the 
falls group were separated into male and females and compared to the control group 
(0.36<P<0.54). (Appendix 1). 
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6.4 Discussion 
The aim of this study was to determine if the genetic frequency of specific 
polymorphisms, which have been linked to muscle function, was different in frequent 
fallers compared to a reference control population. No differences between groups were 
observed. 
This study endeavoured to avoid the potentially confounding effects of ethnic diversity 
by recruiting UK Caucasian volunteers. Patients were excluded if they suffered from 
fainting or blackouts (syncope), or from diseases of the muscular or nervous system (e.g. 
myositis, muscular dystrophy, myopathy, Parkinson'S, stroke) in order to highlight the 
association of genes with muscle function and their predisposition to falls. The present 
study was found to be underpowered to detect a significant genotypic effect. Power and 
sample size calculations indicated that detection of an odds ratio of 1.5 at a 5% 
significance level and 80% power, required larger frequent fallers and control groups 
(ACE, 194; ACTN3, 173) than was the case for the current study. The odds ratio of 1.5 
indicates an effect size of 50% higher risk in the falls group as demonstrated by 
QUANTO (http://hydra.usc.edu/gxe). 
The control group genotype frequencies for this study were obtained from the cohorts 
included in Chapters 3 and 5. The cohorts were not similarly aged matched and selective 
survival may have influenced genotype frequencies which suggests the use of a control 
group with a similar age. The falls group consisted of male and females, their genotype 
frequencies were compared to the control group of males only. It is common for male and 
female data to be considered together in genotype studies; various reports on ACE and 
ACTN3 genotype-muscle function phenotype association studies have included mixed 
sex cohorts (Moran et al., 2007; Delmonico et al., 2008). Additionally the distribution of 
ACE and ACTN3 genotypes are similar for males and females with no difference being 
reported between groups in previous studies (Giaccaglia et al., 2008; Clarkson et al., 
2005). ACE and ACTN3 genotypes were in HWE equilibrium for all groups which gives 
confidence that there was no selection bias. 
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It is important to identify individuals most at risk of falling, as they should be prioritised 
for receiving targeted interventions aimed at reducing the incidence of falls (Pijnappels et 
al., 2008). Considering the impact of falls on the prevalence of health problems (Lord 
and Dayhew, 2001), health care costs (Stevens et al., 2006) and to quality of life it is 
imperative to further investigate factors contributing to fall risk. Reduced muscle strength 
and power have been identified as one of the most important risk factors for falls (Lord et 
al., 2003; Skelton et al., 2002) and since the genetic contribution to muscle strength and 
power appears to be 30-80% it is plausible that the genetic pattem of specific genes, that 
have been linked to muscle function, could be different in frequent fallers compared to a 
reference population and help to highlight individuals most at risk. However the present 
study found no difference in ACE and ACTN3 genotype distributions in frequent fallers. 
Fall risk however, is known to be multifactorial (Carter et al., 2001). Aside from age 
related changes in muscle, predisposition to falls includes age related deterioration of the 
3 sensory systems that control posture; the vestibular, visual and somatosensory systems. 
In the otolith of the ear individuals over 70years of age have 40% fewer sensory cells 
than young adults (Rosenhall et al., 1973). Cutaneous vibratory sensation and joint 
position sense are also diminished in older persons (Skinner et al., 1984). Peripheral 
vision is known to be important in sway stabilisation (Paulus et al., 1984) and low 
frequency spatial information, mediated by the peripheral visual field, deteriorates with 
age (Sekuler and Hutman, 1980). An age-related deterioration in these systems is thought 
to decrease balance and increase postural sway, increasing the possibility of a fall. 
Furthermore medication use such as sedatives and antidepressants are also regarded as 
important contributing factors increasing the risk of falls (Carter et al., 2001). Therefore, 
although a decline in muscle strength is a contributing factor and there is a clear rationale 
that genetic variants which are associated with muscle function (possibly including ACE 
and ACTN3) will also affect falls risk this may not become apparent due to the array of 
factors determining falls risk. 
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The lack of an ACE genotype association with muscle strength of hand grip was similar 
to our previous findings for isometric strength of young and older groups (Chapters 3, 4 
and 5) and a number of other studies (Thomis et al., 2004; Pescatello et al., 2006; 
Hopkinson et al., 2004; Frederikson et al., 2003). Williams et a!. (2005) are the only 
study to have demonstrated a DD association with isometric strength albeit in younger 
people. 
The lack of an association between ACTN3 genotype and isometric handgrip strength is 
similar to a number of other studies in young (Vincent et al., 2007; Clarkson et a!., 2005; 
chapter 3) and older men (Chapter 5; Walsh et al., 2008). However two studies have 
found lower strength in XX genotype women (Clarkson et al., 2005; Walsh et al., 2008), 
indicating a possible sex genotype interaction. Contrastingly no genotype differences 
were observed in females in the current study although the small cohort number may 
likely explain the lack of an observed effect. The association of ACTN3 genotype with 
anthropometric measurements was not observed which is in contrast to our previous 
study for a trend of higher body mass in XX individuals compared to RR genotype 
individuals. Again the small cohort may help explain this contrast in findings. 
Additionally participants were measured in a hospital day clinic and were measured while 
fully clothed and therefore exact body mass was not obtained. 
It is difficult to draw firm conclusions at present, but this initial evidence suggests that 
the distribution of ACE and ACTN3 genotypes do not differ between frequent fallers and 
a healthy control population. 
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CHAPTER 7 
GENERAL DISCUSSION 
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7.1 Associations of ACE lID genotype and serum ACE activity with 
muscle function 
The aim of this research was to investigate the association of two candidate gene (ACE 
lID and ACTN 3 RIX) polymorphisms with the muscle function of young and older men, 
and the distribution of these genotypes in frequent fallers compared to controls. 
Particularly novel aspects of this work were the investigation of any association of these 
gene variants with strength at high velocities and the time course of an evoked twitch. 
This series of studies revealed no ACE genotype association with any measure of muscle 
function, contractile properties or body composition in these populations. Serum ACE 
activity appears to be weakly associated with knee extensor and elbow flexor isometric 
strength in older men, and negatively correlated with the relative torque at high velocity. 
ACTN3 genotype was associated with fat mass in older men but was not associated with 
any measure of muscle function, contractile properties or muscularity. Finally there was 
no apparent difference in the distribution of ACE lID and ACTN3 RlX genotypes 
between frequent fallers and controls. 
The lack of an ACE genotype association with muscle strength and contractile properties. 
across three studies provides confidence that ACE has at most a small association with 
the muscle function of healthy UK Caucasian men. This concurs with the majority of 
studies in this field and in particular with the research on large cohorts that has been 
published during the course of the current research (pescatello et al., 2006; Moran et al., 
2006; Charbonneau et al., 2008). 
Chapters 3 and 5 both showed that ACE genotype was associated with serum ACE 
activity (young and older DD individuals displayed higher serum ACE activity) which is 
in keeping with the established literature (Rigat et al., 1990; Danser et al., 1995). Serum 
ACE activity was not associated with any muscle function measurement of young men, 
but was associated with the knee extensor and elbow flexor isometric strength of older 
men. This indicates a weak association of serum ACE activity with these aspects of 
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muscle function with ageing (coefficients of determination 4 %). The only other study to 
have examined this issue found positive correlations between serum ACE activity and 
strength, but in young men (Williams et al., 2005), which makes it difficult to draw firm 
conclusions at this point. The contrasting findings of Chapters 3 and 5 with regard to 
serum ACE activity could have been due to the superior reliability of the muscle function 
data collected for Chapter 5. The between session CV for the range of muscle function 
measurements was lower for Chapter 5 (2.6 - 8.3%) than Chapter 3 (3.3 - 13.8%). 
Although, the fact that the variability of knee extensor isometric strength measurements 
was similar negates this possibility (Chapter 3, CV 3.2%, Chapter 5, CV 3.4 %). 
Furthermore the larger cohort number in Chapter 5 (n=IOO) compared to the smaller 
number of Chapter 3 (n= 79) and of Williams et al. (2005) (n=Sl) may partly explain the 
contrast in finding with regard to serum ACE activity. The results do however support the 
use of ACE activity measures as well as genotype in the conduct of f~ture studies. This 
may be due to the former being a continuous variable, which is more powerful for 
seeking an association than a categorical variable (genotype): 
The relative torque at high velocity was negatively correlated with serum ACE activity in 
older, but not young men. Serum ACE catalyses the production of ANG n, which has 
been found to promote the preferential hypertrophy of slow twitch fibres (Gordon et al., 
2001), and this could explain a steeper decline in strength as velocity increases. It is 
possible that this effect accrues over the lifespan. 
Chapters 3, 4 and 5 consistently found no ACE genotype relationship with muscularity, 
fat free mass and body composition. As muscle size is a key determinant of muscle 
strength (Folland and WiIIiams, 2007) the similar muscularity of the three ACE 
genotypes is coherent with the findings of no ACE genotype association with strength. It 
is in contrast however with a recent report for an association of ACE genotype with the 
muscle volume of healthy older men and women (Charbonneau et al., 200S). 
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7.2 Associations of ACTN RIX genotype with muscle function and body 
composition 
The findings of this thesis revealed no association of ACTN3 genotype with any 
measures of muscle function, which provides confidence that ACTN3 has at most a small 
association with the muscle function of healthy UK Caucasian men. This is supported by 
a number of other recent studies in men (Clarkson et al 2005; Delmonico et al 2007; 
Delmonico et al 2008), although there are conflicting findings in women (Clarkson et al 
2005; Walsh et al., 2008) that could indicate a sex-genotype interaction. 
As Vincent et al. (2007) did find an association of ACTN3 genotype with relative high 
velocity torque at 300°·s·\, it is possible that the measurement velocities in this thesis 
were insufficient to detect any functional association of ACTN3 genotype. However their 
functional measurements were coincident with an ACTN3 genotype difference in fibre 
type composition, which have since been questioned (Norman et al., 2009). The 
evidence from this work is that any association of ACTN3 genotype on muscle 
composition or contraction does not appear to be of sufficient magnitude to influence the 
contractile or functional properties of human muscle. Furthermore these findings are in 
stark contrast to the proposed role of AC'FN3 in type IIX fibres (MacArthur and North, 
2007). 
There is a clear contrast across the 3 studies on the association of ACTN3 genotype with 
fat mass. The young men from Chapter 3 and the older men from Chapter 4 displayed no 
apparent differences in fat mass between ACTN3 genotypes. However in Chapter 5 XX 
individuals displayed greater fat mass than RR and RX genotypes as well as a tendency 
for higher body mass, something that wasn't found in Chapters 3 and 4. The results from 
Chapter 5 support the hypothesis for ACTN3 as a candidate metabolic ally 'thrifty' 
genotype (Neel, 1962). The absence of ACTN3 from muscle fibres has been hypothesised 
to promote a more efficient use of energy that would likely reduce energy use and 
increase energy storage and provides a likely explanation for the greater adiposity of 
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older XX genotype men. One possible explanation for the lack of ACTN3 genotype 
differences in Chapters 3 and 4 compared with Chapter 5 is that the use of skinfolds as an 
estimate of body fatness is arguably a less sensitive method of body composition 
assessment than a DXA scan. However this does not provide an explanation for the 
contrast in findings by Walsh et al. (2008) that employed DXA and found no ACTN3 
association with the body composition of men (Walsh et al., 2008). However it is 
possible that subtle genetic influences on energy balance may only become apparent over 
a prolonged period of several decades. 
7.3 Indirect indices of skeletal muscle fibre type composition 
There is some evidence that both ACE lID and ACTN3 RIX polymorphisrns could be 
associated with skeletal muscle fibre type composition (Zhang et al., 2003; Vincent et al., 
2007). However, the direct assessment of fibre type in the large populations is 
problematic, and therefore indirect measurements of fibre type composition (e.g. relative 
high velocity torque, and timecourse of an evoked twitch) may have some utility for 
investigating this idea. Whilst there is evidence that both of these measures may 
distinguish for substantial differences in fibre type (Hamada et al., 2000; Gur et a!., 2003) 
they may have limited sensitivity to detect small differences. Using both of these indirect 
indicies of fibre type composition the current work found no evidence to support the 
association of the studied genes with fibre type composition. In addition subsequent 
biopsy studies have also contradicted the initial reports and not found any association of 
these genotypes with fibre type composition (ACE, Akmetov et al., 2006; ACTN3, 
Norman et al., 2009). 
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7.4 The influence of ageing on strength 
An obvious difference in strength was observed when comparisons were made between 
strength measures of the young (Chapter 3) and older men (Chapter 5). Isometric knee 
extensor strength was 20% lower in the older men compared with the young men (610 vs. 
487 N). Isokinetic knee extensor torque at 0, 30 and 240°·s·' was 25, 20 and 29% lower in 
the older men compared to the young (O°·s·' 247 vs 189, 30·os·' 201 vs 160, 240°·s·' 118 
vs 84 Nm). The torque ratio was 10% lower in the older men compared with the young 
men (59 vs 53 %). The lower strength values in the older men compared with the young 
men (Bassey et al., 1993; Frontera et al., 2000; Frontera et al., 1991) are consistent with· 
the literature that there is a decline in strength with ageing. The greatest difference 
between the groups was at the highest velocity (240°·s·') which is likely due to 
preferential atrophy oftype II fibres (Larsson et al., 1978) and emphasises the inability to 
maintain torque at high velocity as a consequence of ageing. 
7.5 Genotype distribution between frequent fallers and controls 
Whilst Chapter 6 found no differences in ACE and ACTN3 genotypes between the 
frequent fallers and controls, the small cohort is a major limitation of this investigation 
which was underpowered to detect anything other than a very dramatic genotypic effect. 
Power and sample size calculations suggested that a cohort of 194 (for ACE) and 173 (for 
ACTN3) in each group is necessary in order to detect any association with an odds ratio 
of 1.5 (5% significance level and 80% power). Furthermore, handgrip strength did not 
differ between ACE and ACTN3 genotypes in either men or women, which is consistent 
with the previous 3 studies. Additionally it is important to consider the statistical power 
of chapters 3, 4 and 5 in relation to the participant numbers. Post hoc power statistics 
were performed to determine the effect size for differences in muscle strength that could 
be detected between genotypes using the sample sizes employed in Chapters 3, 4 and 5. 
Results showed that at 80% power the effect size for chapter 3 was .93, chapter 4 was .77 
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and chapter 5 was .82. According to Cohen's (1988) conventional criterion the sample 
size employed was sufficient to have detected a medium to large effect size and therefore 
unlikely to have detected a small effect for differences in muscle strength between 
genotypes. 
7.6 Contrasting findings of case-control and association stndies 
Before this current work began there were relatively few studies published highlighting 
the potential association of ACE and ACTN3 genotype with muscle phenotypes and the 
literature was equivocal and inconclusive which gave the premise for the current work to 
focus on the ACE IID and ACTN3 RJX gene polymorphisms. Since then there have been 
numerous new studies published investigating the association of these polymorphisms 
with muscle phenotypes. There is a clear contrast in the literature regarding reports from 
case control studies of athletes and association studies of the normal population. The 
majority of association studies, many of which have been published since the start of this 
thesis, have found no ACE and ACTN3 genotype association with muscle function, 
(Giaccaglia et al., 2008; Charbonneau et al., 2008; Pescatello et al., 2006; Thomis et al., 
2004; Delmonico et al., 2008; Moran et al., 2007) and are in contrast with the case-
control studies, that have reported the DD genotype of the ACE gene and the RR 
genotype of the ACTN3 gene to be overrepresented in elite athletic events requiring 
muscle power (Myerson et al., 1999; Nazarov et al., 2001; Jones and Montgomery, 2002; 
Woods et al., 200la; Roth et al., 2008; Druzhevskay et al., 2008; ). It may be that the 
association of ACE and ACTN3 genotype with muscle function is only apparent in the 
extreme phenotypes such as that of elite athletes and might indicate an interaction with 
powerful long-term environmental factors e.g. physical activity and training. Despite the 
initial excitement about these polymorphisms, ACE and ACTN3 do not appear to be 
associated with muscle function phenotypes in healthy untrained men. 
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7.7 Future Directions 
• A number of other candidate gene polymorphisms (e.g. insulin like growth factor 
(IGF) 11 and vitamin D like receptor (VDR) BsmI and VDR Poly A) have been 
suggested to have an association with muscle function phenotypes and these 
should be investigated. 
• It is becoming apparent that the association of single gene polymorphisms may be 
limited, and large cohort studies are recommended to detect potentially small 
effects and reduce the chance of 'false positives' that may explain some of the 
contradictions in the existing literature. 
• Given that the association of a single gene variant is probably quite small, 
multiple gene studies are also recommended in order to determine broader genetic 
effects on a given phenotype. 
• There are likely complex Gene x Gene interactions in which certain 
polymorphisrns may modify the association of other genes, under certain 
conditions which require further research. 
• As well as the possible gene-environment (physical training) interaction 
suggested for elite athletes there are likely complex Gene x Environment 
interactions (e.g. nutrition) not yet explored that could help to explain inter 
individual variability in muscle phenotypes. 
• Investigations involving cohorts from single ethnic origins, with a similar age 
range and physical activity status are required in order to overcome limitations of 
previous work. 
• Investigations of ACE genotype should routinely include measurement of serum 
ACE activity and where possible tissue ACE activity. 
• The focus upon ACTN3 and its association with body composition warrants 
further attention given the widely documented influence of body fatness on 
overall health, morbidity and mortality. 
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• The only study to date that reported an ACTN3 genotype association with 
isokinetic strength at high velocity in young males supports the use of faster 
velocities in future studies 
• The possible sex-ACTN3 genotype interaction requires further investigation. 
• As the study of genotype distribution in frequent fallers (Chapter 6) was limited 
due to the small cohort, continuation of this work is recommended to find out if 
there are genetic factors that predispose to falls risk. 
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Table A.I Percentage of ACE and AC1N3 genotypes in male falls group vs control group 
ACE ACTN3 
11 ID DD RR RX XX 
Falls group n 9 12 5 11 13 3 
(%) (34.6) (46.2) (19.2) (40.7) (48.2) (11.1) 
Control group n 42 88 49 70 78 31 
(%) (23.4) (49.2) (27.4) (39.1 ) (43.6) (17.3) 
Table A.2 Percentage of ACE and AC1N3 genotypes in female falls group vs control group 
ACE ACTN3 
11 ID DD RR RX XX 
Falls group n 10 21 12 14 22 8 
(%) (23.3) (48.8) (27.9) (31.8) (50) (18.2) 
Control group n 42 88 49 70 78 31 
(%) (23.4) (49.2) (27.4) (39.1) (43.6) (17.3) 
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